Case number 1:18-cv-01689
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Lupin Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 12, 2023 | 484 | SO ORDERED, re 483 Proposed Consent Judgment. Party InvaGen Pharmaceuticals, Inc., Cipla Limited and Cipla USA, Inc. terminated. Signed by Judge Colm F. Connolly on 9/12/2023. (nmf) (Entered: 09/12/2023) (5) |
| Sep 6, 2023 | 483 | PROPOSED CONSENT JUDGMENT as to Defendants Cipla Limited, Cipla USA, Inc. and InvaGen Pharmaceuticals, Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 09/06/2023) (5) |
| Jul 28, 2023 | 482 | Joint STATUS REPORT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 07/28/2023) (3) |
| Jun 13, 2023 | 481 | SO ORDERED, re 480 STIPULATION TO EXTEND TIME for Defendants to conduct a Rule 30(b)(6) deposition and for the parties to file a joint status report to July 24, 2023 and July 28, 2023, respectively, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Resetting Deadlines: Status Report due by 7/28/2023. Signed by Judge Colm F. Connolly on 6/13/2023. (kmd) (Entered: 06/13/2023) (2) |
| Jun 9, 2023 | 480 | STIPULATION TO EXTEND TIME for Defendants to conduct a Rule 30(b)(6) deposition and for the parties to file a joint status report to July 24, 2023 and July 28, 2023, respectively - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 06/09/2023) (2) |
| May 18, 2023 | 479 | CONSENT JUDGMENT as to Laurus Labs Ltd. and Laurus Generics, Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. Party Laurus Labs Ltd. and Laurus Generics Inc. terminated. Signed by Judge Colm F. Connolly on 5/18/2023. (nmf) (Entered: 05/18/2023) (4) |
| May 17, 2023 | 478 | PROPOSED CONSENT JUDGMENT as to Laurus Labs Ltd. and Laurus Generics, Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 05/17/2023) (4) |
| May 5, 2023 | 477 | STIPULATION TO EXTEND TIME for defendants to conduct a Rule 30(b)(6) deposition (D.I. 471) and for the parties to file a joint status report (id.) to June 12, 2023 and June 16, 2023, respectively - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 05/05/2023) (3) |
| Feb 14, 2023 | 475 | PROPOSED CONSENT JUDGMENT Between Boehringer and Mankind and LifeStar Defendants by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 02/14/2023) (6) |
| Feb 14, 2023 | 476 | CONSENT JUDGMENT Between Boehringer and Mankind and LifeStar Defendants by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. Party Lifestar Pharma LLC and Party Mankind Pharma Ltd. terminated. Signed by Judge Colm F. Connolly on 2/14/2023. (nmf) (Entered: 02/14/2023) (6) |
| Jan 30, 2023 | 474 | STIPULATION TO EXTEND TIME for Plaintiffs to serve a privilege log to February 7, 2023 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 01/30/2023) (3) |
| Dec 12, 2022 | 473 | CONSENT JUDGMENT, Party Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd. terminated. Signed by Judge Colm F. Connolly on 12/12/2022. (nmf) (Entered: 12/12/2022) (6) |
| Dec 9, 2022 | 472 | PROPOSED CONSENT JUDGMENT Between Boehringer and the Aurobindo Defendants by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 12/09/2022) (6) |
| Nov 18, 2022 | 471 | ORDER re: discovery. STATUS REPORT ORDER:( Status Report due by 5/9/2023.) Signed by Judge Colm F. Connolly on 11/18/2022. (nmf) (Entered: 11/18/2022) (2) |
| Nov 17, 2022 | 470 | PROPOSED ORDER reflecting rulings made by the Court during the November 9, 2022 hearing re 468 Transcript,, by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Phillips, John) (Entered: 11/17/2022) (2) |
| Nov 16, 2022 | 469 | STIPULATION TO EXTEND TIME for the parties to file a Proposed Order reflecting rulings made during the November 9, 2022 Hearing to November 17, 2022 - filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Phillips, John) (Entered: 11/16/2022) (2) |
| Nov 14, 2022 | 468 | Official Transcript of Discovery Conference held on November 9, 2022 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/5/2022. Redacted Transcript Deadline set for 12/15/2022. Release of Transcript Restriction set for 2/13/2023. (nmf) (Entered: 11/14/2022) (111) |
| Nov 4, 2022 | 466 | REDACTED VERSION of 462 MOTION to Compel by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Attachments: # 1 Exhibits 1-13, # 2 Proposed Order, # 3 Word Count Compliance, # 4 Certificate of Service)(Phillips, John) (Entered: 11/04/2022) (Main Document) (10) |
| Nov 4, 2022 | 467 | REDACTED VERSION of 463 Response to Motion, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # 1 Exs. 1-8)(Dellinger, Megan) (Entered: 11/04/2022) (Main Document) (12) |
| Nov 4, 2022 | 467 | REDACTED VERSION of 463 Response to Motion, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # 1 Exs. 1-8)(Dellinger, Megan) (Entered: 11/04/2022) (Exs. 1-8) (30) |
| Nov 4, 2022 | 466 | REDACTED VERSION of 462 MOTION to Compel by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Attachments: # 1 Exhibits 1-13, # 2 Proposed Order, # 3 Word Count Compliance, # 4 Certificate of Service)(Phillips, John) (Entered: 11/04/2022) (Exhibits 1-13) (30) |
| Nov 4, 2022 | 466 | REDACTED VERSION of 462 MOTION to Compel by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Attachments: # 1 Exhibits 1-13, # 2 Proposed Order, # 3 Word Count Compliance, # 4 Certificate of Service)(Phillips, John) (Entered: 11/04/2022) (Proposed Order) (2) |
| Nov 4, 2022 | 466 | REDACTED VERSION of 462 MOTION to Compel by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Attachments: # 1 Exhibits 1-13, # 2 Proposed Order, # 3 Word Count Compliance, # 4 Certificate of Service)(Phillips, John) (Entered: 11/04/2022) (Word Count Compliance) (1) |
| Nov 4, 2022 | 466 | REDACTED VERSION of 462 MOTION to Compel by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Attachments: # 1 Exhibits 1-13, # 2 Proposed Order, # 3 Word Count Compliance, # 4 Certificate of Service)(Phillips, John) (Entered: 11/04/2022) (Certificate of Service) (1) |
| Oct 31, 2022 | 465 | SO ORDERED, re 464 STIPULATION TO EXTEND TIME for Defendants to file a redacted version of their Motion to Compel (D.I. 462) to November 4, 2022, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 10/31/2022. (kmd) (Entered: 10/31/2022) (3) |
| Oct 28, 2022 | 463 | [SEALED] RESPONSE to Motion re 462 MOTION to Compel filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1-8)(Blumenfeld, Jack) (Main Document 463 replaced on 11/1/2022) (nmf, ). (Entered: 10/28/2022) (0) |
| Oct 28, 2022 | 464 | STIPULATION TO EXTEND TIME for Defendants to file a redacted version of their Motion to Compel (D.I. 462) to November 4, 2022 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 10/28/2022) (3) |
| Oct 21, 2022 | 462 | [SEALED] MOTION to Compel - filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Attachments: # 1 Exhibits 1-6, # 2 Exhibits 7-13, # 3 Proposed Order, # 4 Certificate of Compliance, # 5 Certificate of Service)(Phillips, John) Modified on 10/21/2022 (nmf). (Entered: 10/21/2022) (0) |
| Sep 14, 2022 | 461 | NOTICE requesting Clerk to remove Michael K. Nutter as co-counsel. Reason for request: No longer affiliated on the case. (Bilson, David) (Entered: 09/14/2022) (2) |
| Aug 10, 2022 | 460 | NOTICE of Appearance by Alexis Stombaugh on behalf of Laurus Generics Inc., Laurus Labs Ltd. (Stombaugh, Alexis) (Entered: 08/10/2022) (3) |
| Jul 25, 2022 | 459 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Jason Z. Pesick as co-counsel. Reason for request: No Longer with Winston & Strawn LLP. (Bilson, David) |
| Jun 14, 2022 | 458 | Letter (4) Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding joint letter regarding discovery dispute. (Phillips, John) |
| May 2, 2022 | 456 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by James G. Gorman, III on behalf of Lifestar Pharma LLC, Mankind Pharma Ltd. (Gorman, James) |
| Apr 13, 2022 | N/A | Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - In-Person Status Conference held on 4/13/2022. (Court Reporter Bonnie Archer.) Associated Cases: 1:18-cv-01689-CFC-SRF et al.(nmf) |
| Apr 11, 2022 | 455 | Notice Requesting Removal of Co-Counsel (8) Docket Text: NOTICE requesting Clerk to remove Matthew A. Lembo as co-counsel. Reason for request: No Longer with Firm. (Dellinger, Megan) |
| Apr 6, 2022 | 454 | Motion to Withdraw (1) Docket Text: NOTICE of Withdrawal of the Appearance of Brandon McCune, Esq. - filed by Lifestar Pharma LLC, Mankind Pharma Ltd.. (Orlacchio, Adam) Modified on 4/11/2022 (kmd). |
| Apr 5, 2022 | 452 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Anna Elizabeth Currier on behalf of Lifestar Pharma LLC, Mankind Pharma Ltd. (Currier, Anna) |
| Apr 5, 2022 | 453 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Adam V. Orlacchio on behalf of Lifestar Pharma LLC, Mankind Pharma Ltd. (Orlacchio, Adam) |
| Mar 31, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER- Whereas, I find this case is an exceptional one for which ADR is appropriate, I will continue to mediate this matter in accordance with the original referral made in the Oral Order of 3/15/2019. Ordered by Judge Sherry R. Fallon on 3/31/2022. (lih) |
| Mar 15, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Dipu A. Doshi for Lifestar Pharma LLC, Mankind Pharma Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Mar 14, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [451] MOTION for Pro Hac Vice Appearance of Attorney Dipu A. Doshi, filed by Lifestar Pharma LLC, Mankind Pharma Ltd. Ordered by Judge Colm F. Connolly on 3/14/2022. (kmd) |
| Mar 14, 2022 | 451 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dipu A. Doshi - filed by Lifestar Pharma LLC, Mankind Pharma Ltd.. (Orlacchio, Adam) |
| Feb 11, 2022 | 450 | Notice Requesting Removal of Co-Counsel (6) Docket Text: NOTICE requesting Clerk to remove Mira A. Mulvaney as co-counsel. Reason for request: No longer with firm. (Dellinger, Megan) |
| Feb 2, 2022 | 449 | Notice Requesting Removal of Co-Counsel (6) Docket Text: NOTICE requesting Clerk to remove Christopher J. Citro and Jessica Lam as co-counsel. Reason for request: No longer with firm. (Dellinger, Megan) |
| Jan 31, 2022 | 448 | Redacted Document (30) Docket Text: REDACTED VERSION of [446] Status Report, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Nov 8, 2021 | 447 | Notice (Other) (3) Docket Text: NOTICE of Withdrawal of Beth A. Swadley by Laurus Generics Inc., Laurus Labs Ltd. (Poff, Adam) |
| Oct 19, 2021 | 445 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT, Party MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc. terminated. Signed by Judge Colm F. Connolly on 10/18/2021. (nmf) |
| Oct 14, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [444] STIPULATION TO EXTEND TIME to submit a status report and proposed revised scheduling order as set forth in the Court's July 8, 2021 Oral Order to October 29, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 10/14/2021. (kmd) |
| Oct 13, 2021 | 444 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit a status report and proposed revised scheduling order as set forth in the Court's July 8, 2021 Oral Order to October 29, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Oct 8, 2021 | 443 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Sep 14, 2021 | 442 | SO ORDERED (3) Docket Text: SO ORDERED, re [441] STIPULATION TO EXTEND TIME for parties to submit a status report and proposed revised Scheduling Order to October 15, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 9/14/2021. (nmf) |
| Sep 13, 2021 | 441 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for parties to submit a status report and proposed revised Scheduling Order to October 15, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Sep 7, 2021 | 440 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Kevin E. Warner as co-counsel. Reason for request: No Longer with the Firm. (Bilson, David) |
| Aug 17, 2021 | 439 | Order Setting Mediation Conferences (4) Docket Text: ORDER Setting Video Mediation Conferences: A Video Mediation Conference is set for 8/31/2021 at 10:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 8/17/2021. (lih) |
| Aug 13, 2021 | 438 | Notice (Other) (2) Docket Text: NOTICE of the Withdrawal of Brandon R. Harper as Counsel of Record by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Connolly, Arthur) |
| Aug 9, 2021 | 437 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Adam Orlacchio as co-counsel. Reason for request: Resignation. (Orlacchio, Adam) |
| Jul 30, 2021 | 436 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Appearance of Stephanie S. Riley by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Connolly, Arthur) |
| Jul 28, 2021 | 435 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT, Party Alkem Laboratories Ltd. terminated. Signed by Judge Colm F. Connolly on 7/28/2021. (nmf) |
| Jul 27, 2021 | 433 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Jul 27, 2021 | 434 | Consent Judgment (5) Docket Text: CONSENT JUDGMENT: Party Cadila Healthcare Limited and Zydus Pharmaceuticals (USA) Inc. terminated. Signed by Judge Colm F. Connolly on 7/26/2021. (nmf) |
| Jul 23, 2021 | 432 | Proposed Consent Judgment (5) Docket Text: PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Jul 8, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 7/8/2021. (Court Reporter V. Gunning.) (nmf) |
| Jul 6, 2021 | 431 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to Notify the Court of the Final Election of Asserted Claims and Prior Art Defenses to July 15, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jun 28, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [426] Letter, ORDER Setting Teleconference: Counsel for Plaintiff to coordinate the call and email the dial-in information to chambers.( A Telephone Conference is set for 7/8/2021 at 08:00 AM before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 6/28/2021. (nmf) |
| Jun 28, 2021 | 430 | SO ORDERED (3) Docket Text: SO ORDERED, re [428] Joint STIPULATION TO EXTEND TIME to Notify the Court of the Final Election of Asserted Claims and Prior Art Defenses to July 6, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 6/28/2021. (nmf) |
| Jun 24, 2021 | 429 | Order Setting Mediation Conferences (4) Docket Text: ORDER Setting Telephonic Mediation Conference: A Telephonic Mediation Conference is set for 7/7/2021 at 10:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 6/24/2021. (lih) |
| Jun 23, 2021 | 428 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to Notify the Court of the Final Election of Asserted Claims and Prior Art Defenses to July 6, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jun 21, 2021 | 426 | Letter (1) Docket Text: Letter to the Honorable Colm F. Connolly from John C. Phillips, Jr. regarding Letter from Defendants about recent development that may affect the scope & schedule of trial. (Phillips, John) |
| Jun 21, 2021 | 427 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding Response to Defendants' June 21, 2021 Letter - re [426] Letter. (Dellinger, Megan) |
| Jun 11, 2021 | 425 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Ryan A. Cook as co-counsel. Reason for request: no longer associated with the case. (Phillips, John) |
| Jun 9, 2021 | 424 | Order Setting Mediation Conferences (6) Docket Text: ORDER Setting Video Mediation Conference: A Video Mediation Conference is set for 8/12/2021 at 10:30 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 6/9/2021. (lih) |
| Jun 4, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jeanna M. Wacker,Sam Kwon,Christopher J. Citro for Boehringer Ingelheim Corporation, for Boehringer Ingelheim International GmbH,for Boehringer Ingelheim Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jun 4, 2021 | 423 | Order Setting Mediation Conferences (6) Docket Text: ORDER Setting Video Mediation Conference: A Video Mediation Conference is set for 6/22/2021 at 10:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 6/4/2021. (lih) |
| Jun 1, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [422] STIPULATION TO EXTEND TIME the deadline for the simultaneous exchange of initial witness lists and designation of whether witnesses will be called live or by deposition to June 18, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 6/1/2021. (fms) |
| May 28, 2021 | 422 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME the deadline for the simultaneous exchange of initial witness lists and designation of whether witnesses will be called live or by deposition to June 18, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| May 25, 2021 | 421 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT as to Plaintiffs and Defendant Aizant Drug Research Solutions Pvt. Ltd. Signed by Judge Colm F. Connolly on 5/25/2021. (nmf) |
| May 24, 2021 | 420 | Order Setting Mediation Conferences (6) Docket Text: ORDER Setting Video Mediation Conference: A Video Mediation Conference is set for 6/24/2021 at 10:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 5/24/2021. (lih) |
| May 21, 2021 | 419 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT as to Plaintiffs and Defendant Aizant Drug Research Solutions Pvt. Ltd. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| May 20, 2021 | 417 | Order Setting Mediation Conferences (6) Docket Text: ORDER Setting Video Mediation Conference: A Video Mediation Conference is set for 6/21/2021 at 10:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 5/20/2021. (lih) |
| May 20, 2021 | 418 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT as to Plaintiffs and Defendant Prinston Pharmaceutical Inc. Signed by Judge Colm F. Connolly on 5/19/2021. (nmf) |
| May 18, 2021 | 416 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT - by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| May 13, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Serena Gopal for Lifestar Pharma LLC and Mankind Pharma Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| May 7, 2021 | 415 | SO ORDERED (6) Docket Text: SO ORDERED, re [414] Stipulation filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 5/7/2021. (fms) |
| May 6, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [413] MOTION for Pro Hac Vice Appearance of Attorney Christopher Hu filed by Lifestar Pharma LLC, Mankind Pharma Ltd. Signed by Judge Colm F. Connolly on 5/6/2021. (fms) |
| May 6, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher K. Hu for Lifestar Pharma LLC, for Mankind Pharma Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| May 6, 2021 | 413 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher Hu - filed by Lifestar Pharma LLC, Mankind Pharma Ltd.. (Orlacchio, Adam) |
| May 6, 2021 | 414 | Stipulation (6) Docket Text: STIPULATION and [Proposed] Order for Pretrial Schedule by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| May 5, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher T. Jagoe for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| May 5, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 5/5/2021. (Court Reporter V. Gunning.) (nmf) |
| Apr 28, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [407] Joint Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding Case Narrowing., ORDER Setting Teleconference: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers. (A Telephone Conference is set for 5/5/2021 at 10:00 AM before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 4/28/2021. (nmf) |
| Apr 28, 2021 | 412 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT, Party Alembic Pharmaceuticals, Inc. and Alembic Pharmaceuticals Ltd. terminated. Signed by Judge Colm F. Connolly on 4/27/2021. (nmf) |
| Apr 26, 2021 | 411 | SO ORDERED (3) Docket Text: SO ORDERED, re [408] Stipulation and Order Regarding Privilege Logs filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 4/26/2021. (fms) |
| Apr 23, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [410] MOTION for Pro Hac Vice Appearance of Attorney Serena Gopal filed by Lifestar Pharma LLC, Mankind Pharma Ltd. Signed by Judge Colm F. Connolly on 4/23/2021. (fms) |
| Apr 23, 2021 | 409 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT between Plaintiffs and Defendants Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Apr 23, 2021 | 410 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Serena Gopal - filed by Lifestar Pharma LLC, Mankind Pharma Ltd.. (Orlacchio, Adam) |
| Apr 22, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [406] MOTION for Pro Hac Vice Appearance of Attorney Katherine M. Tassmer filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 4/22/2021. (fms) |
| Apr 22, 2021 | 406 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Katherine M. Tassmer - filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Farnan, Kelly) |
| Apr 22, 2021 | 407 | Letter (6) Docket Text: Joint Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding Case Narrowing. (Dellinger, Megan) |
| Apr 22, 2021 | 408 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Privilege Logs by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Apr 19, 2021 | 405 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Michael J. Zaworotko, Ph.D. on May 4, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Apr 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [404] STIPULATION TO EXTEND TIME for the parties to submit a joint letter to the Court regarding case narrowing to April 22, 2021 filed by Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Lupin Pharmaceuticals, Inc., MSN Pharmaceuticals Inc., Cipla Limited, Cipla USA, Inc., InvaGen Pharmaceuticals, Inc., MSN Laboratories Private Ltd., Lupin Ltd., Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 4/16/2021. (fms) |
| Apr 15, 2021 | 404 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a joint letter to the Court regarding case narrowing to April 22, 2021 - filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) |
| Apr 13, 2021 | 403 | Main Document (5) Docket Text: REDACTED VERSION of [390] Letter by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Exhibits 4-8)(Dellinger, Megan) |
| Apr 13, 2021 | 403 | Exhibits 4-8 (48) |
| Apr 12, 2021 | 392 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. Leonard J. Chyall Pursuant to Federal Rule of Civil Procedure 30(b)(1) on April 28, 2021 filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Phillips, John) |
| Apr 12, 2021 | 393 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. Jerry L. Atwood Pursuant to Federal Rule of Civil Procedure 30(b)(1) on May 13, 2021 filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Phillips, John) |
| Apr 12, 2021 | 394 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. William R. Roush Pursuant to Federal Rule of Civil Procedure 30(b)(1) on May 12, 2021 filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Phillips, John) |
| Apr 12, 2021 | 395 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. Allan S. Myerson Pursuant to Federal Rule of Civil Procedure 30(b)(1) on May 5, 2021 filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Phillips, John) |
| Apr 12, 2021 | 396 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. S. David Kimball Pursuant to Federal Rule of Civil Procedure 30(b)(1) on April 23, 2021 filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Phillips, John) |
| Apr 12, 2021 | 397 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of Dr. Mark Williams Pursuant to Federal Rule of Civil Procedure 30(b)(1) on May 3, 2021 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Apr 12, 2021 | 398 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of Dr. Vivian A. Fonseca Pursuant to Federal Rule of Civil Procedure 30(b)(1) on April 30, 2021 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Apr 12, 2021 | 399 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of Dr. James Lenhard Pursuant to Federal Rule of Civil Procedure 30(b)(1) on April 13, 2021 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Apr 12, 2021 | 400 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of Neal M. Davies, BSC (Pharm), Ph.D., R.Ph. Pursuant to Federal Rule of Civil Procedure 30(b)(1) on May 11, 2021 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Apr 12, 2021 | 401 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of Dr. Darren McGuire Pursuant to Federal Rule of Civil Procedure 30(b)(1) on April 16, 2021 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Apr 12, 2021 | 402 | Main Document (5) Docket Text: REDACTED VERSION of [388] Letter by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc.. (Attachments: # (1) Exhibits 1-4, # (2) Proposed Order)(Phillips, John) |
| Apr 12, 2021 | 402 | Exhibits 1-4 (81) |
| Apr 12, 2021 | 402 | Proposed Order (2) |
| Apr 7, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Dispute Telephone Conference held on 4/7/2021. (Court Reporter V. Gunning.) (lih) |
| Apr 7, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER- re [381] Joint MOTION for Teleconference to Resolve Discovery Dispute. The transcript of the 4/7/2021 discovery dispute teleconference shall serve as the order of the court. Ordered by Judge Sherry R. Fallon on 4/7/2021. (lih) |
| Apr 7, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [387] STIPULATION TO EXTEND TIME for the parties to submit a joint letter to the Court regarding case narrowing that contains proposed limits on the number of asserted patent claims and prior art combination references and proposed dates by which such limit filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 4/7/2021. (fms) |
| Apr 6, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [386] MOTION for Pro Hac Vice Appearance of Attorney Sharon Lin filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Lupin Pharmaceuticals, Inc., MSN Pharmaceuticals Inc., Cipla Limited, Cipla USA, Inc., InvaGen Pharmaceuticals, Inc., MSN Laboratories Private Ltd., Lupin Ltd. Signed by Judge Colm F. Connolly on 4/6/2021. (nmf) |
| Apr 6, 2021 | 391 | Main Document (4) Docket Text: Letter to The Honorable Sherry R. Fallon from John C. Phillips, Jr. regarding response to Plaintiffs' April 5, 2021 Discovery Dispute Letter - re [389] Letter. (Attachments: # (1) Exhibits 1-2)(Phillips, John) |
| Apr 6, 2021 | 391 | Exhibits 1-2 (11) |
| Apr 5, 2021 | 389 | Main Document (3) Docket Text: Letter to The Honorable Sherry R. Fallon from Megan E. Dellinger regarding Discovery Dispute . (Attachments: # (1) Exhibit 1-2, # (2) Exhibit 3 - Proposed Order)(Dellinger, Megan) Modified on 4/5/2021 (lih). |
| Apr 5, 2021 | 389 | Exhibit 1-2 (34) |
| Apr 5, 2021 | 389 | Exhibit 3 - Proposed Order (3) |
| Apr 1, 2021 | 386 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Sharon Lin - filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Attachments: # (1) Certification of Sharon Lin)(Bilson, David) |
| Apr 1, 2021 | 386 | Certification of Sharon Lin (1) |
| Apr 1, 2021 | 387 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a joint letter to the Court regarding case narrowing that contains proposed limits on the number of asserted patent claims and prior art combination references and proposed dates by which such limitations must occur (see D.I. 367) to April 15, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Mar 26, 2021 | 385 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Sur-Reply Expert Report of Michael J. Zaworotko, Ph.D. filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 25, 2021 | 384 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of DeForest McDuff, Ph.D. on May 26, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Mar 22, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [383] Stipulation Regarding Sur-Reply Expert Report of Michael J. Zaworotko, Ph.D. filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited. Ordered by Judge Colm F. Connolly on 3/22/2021. (fms) |
| Mar 19, 2021 | 383 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Sur-Reply Expert Report of Michael J. Zaworotko, Ph.D. by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) |
| Mar 15, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [381] Joint MOTION for Teleconference to Resolve Discovery Dispute. A Telephone Conference is set for 4/7/2021 at 02:00 PM before Judge Sherry R. Fallon. In preparation for this hearing the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Set Deadlines: (Moving Submission due by no later than 10:00 AM on 4/5/2021, Responsive submission due by no later than 10:00 AM on 4/6/2021.) Signed by Judge Sherry R. Fallon on 3/15/2021. (lih) |
| Mar 15, 2021 | 382 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Brandon W. McCune on behalf of Lifestar Pharma LLC, Mankind Pharma Ltd. (McCune, Brandon) |
| Mar 12, 2021 | 381 | Motion for Miscellaneous Relief (6) Docket Text: Joint MOTION for Teleconference to Resolve Discovery Dispute - filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc.. Motions referred to Sherry R. Fallon.(Bilson, David) |
| Mar 10, 2021 | 380 | Order Setting Mediation Conferences (6) Docket Text: ORDER Setting Video Mediation Conference: A Video Mediation Conference is set for 4/8/2021 at 10:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 3/10/2021. (lih). |
| Mar 5, 2021 | 379 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Brendan D. O'Callaghan as co-counsel. Reason for request: no longer with firm. (Bilson, David) |
| Feb 26, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [371] MOTION for Pro Hac Vice Appearance of Attorney Mark C. McLennan filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 2/25/2021. (fms) |
| Feb 25, 2021 | 371 | Motion for Leave to Appear Pro Hac Vice (12) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Mark C. McLennan - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Feb 25, 2021 | 372 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of John Bantle on May 7, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Feb 25, 2021 | 373 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of William C. Biggs, M.D. on April 23, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Feb 25, 2021 | 374 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Eric Parker on April 8, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Feb 25, 2021 | 375 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of David Rawlins on May 7, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Feb 25, 2021 | 376 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Peter W. Stephen, Ph.D. on April 2, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Feb 25, 2021 | 377 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Michael J. Zaworotko, Ph.D. on April 28, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Feb 25, 2021 | 378 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Randall M. Zusman, M.D. on April 15, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Feb 22, 2021 | 368 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Reply Expert Report of David B. Rawlins, Ph.D.; [HIGHLY CONFIDENTIAL] Reply Expert Report of Randall M. Zusman, M.D; and [HIGHLY CONFIDENTIAL] Reply Expert Report of Michael J. Zaworotko, Ph.D. filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Feb 22, 2021 | 369 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Reply Expert Report of Dr. John Bantle; [HIGHLY CONFIDENTIAL] Expert Report of DeForest McDuff, Ph.D.; and [HIGHLY CONFIDENTIAL] Reply Expert Report of Eric Parker, Ph.D. filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Feb 22, 2021 | 370 | SO ORDERED (6) Docket Text: SO ORDERED, re [367] Stipulation filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 2/22/2021. (fms) |
| Feb 19, 2021 | 367 | Stipulation (6) Docket Text: STIPULATION and [Proposed] Order Regarding Deadlines by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Feb 12, 2021 | 366 | Notice (Other) (3) Docket Text: NOTICE of of Change of Law Firm Affiliation by Aizant Drug Research Solutions Pvt. Ltd., Prinston Pharmaceutical Inc. (Stamoulis, Stamatios) |
| Jan 29, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 1/29/2021. (Court Reporter V. Gunning.) (nmf) |
| Jan 29, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER Resetting Scheduling Order Deadlines: (The Final Pretrial Conference is rescheduled for 9/8/2021 at 02:00 PM in Courtroom 4B before Judge Colm F. Connolly., Proposed Pretrial Order due by 8/30/2021., The Bench Trial is rescheduled for 9/13/2021 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 1/29/2021. (nmf) |
| Jan 27, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Teleconference: A Telephone Conference is set for 1/27/2021 at 12:30 PM before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 1/27/2021. (nmf) |
| Jan 27, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 1/27/2021. (Court Reporter V. Gunning.) (nmf) |
| Jan 27, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Teleconference: Counsel for Defendants to coordinate the call and email the dial-in information to chambers. A Telephone Conference is set for 1/29/2021 at 02:00 PM before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 1/27/2021. (nmf) |
| Dec 29, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [363] SEALED Stipulation filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 12/29/2020. (fms) |
| Dec 29, 2020 | 365 | Redacted Document (4) Docket Text: REDACTED VERSION of [363] Stipulation and [Proposed] Order of Dismissal of U.S. Patent No. 7,713,938 by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Farnan, Kelly) |
| Dec 28, 2020 | 364 | Notice of Service (18) Docket Text: NOTICE OF SERVICE of (1) Expert Report of Alan Myerson, (2) Rebuttal Expert Report of Mark Williams Regarding Validity of U.S. Patent Nos. 9,949,998 and 10,258,637, (3) Rebuttal Expert Report of Dr. Vivian A. Fonseca Regarding the Validity of U.S. Patent No. 8,551,957, (4) Rebuttal Expert Report of William Roush, Ph.D., (5) Rebuttal Expert Report of Neal M. Davies, BSC(Pharm), Ph.D., R.Ph., (6) Expert Report of Dr. Darren McGuire, M.D., M.H.S.c., (7) Expert Report of Dr. S. David Kimball, and (8) Expert Report of Christopher A. Vellturo, Ph.D. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Dec 23, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Per request of filer, the Amended Disclosure Statement pursuant to Rule 7.1 (formerly D.I. 364) has been removed from the docket. (fms) |
| Dec 16, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [362] STIPULATION TO EXTEND TIME for service of rebuttal and reply expert reports to dates as outlined in the stipulation filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 12/16/2020. (fms) |
| Dec 15, 2020 | 362 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for service of rebuttal and reply expert reports to dates as outlined in the stipulation - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Dec 1, 2020 | 361 | SO ORDERED (4) Docket Text: SO ORDERED, re [360] Stipulation filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 12/1/2020. (fms) |
| Nov 24, 2020 | 360 | Stipulation (4) Docket Text: STIPULATION and Proposed Order Regarding the Validity of Certain Asserted Claims by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Nov 16, 2020 | 359 | Notice of Service (18) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Amended Fourth Set of Common Interrogatories to Plaintiffs (Nos. 14-20) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Nov 10, 2020 | 358 | Consent Judgment (5) Docket Text: CONSENT JUDGMENT, Party Hetero USA Inc. and Annora Pharma Private Limited terminated. Signed by Judge Colm F. Connolly on 11/10/2020. (nmf) |
| Nov 6, 2020 | 357 | Proposed Consent Judgment (5) Docket Text: PROPOSED CONSENT JUDGMENT between Plaintiffs and Annora Pharma Private Ltd. and Hetero USA Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Oct 29, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [356] Joint STIPULATION TO EXTEND TIME to serve opening expert reports to November 6, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Setting Scheduling Order Deadlines ( Opening Expert Reports due by 11/6/2020.). Signed by Judge Colm F. Connolly on 10/29/2020. (fms) |
| Oct 29, 2020 | 356 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME to serve opening expert reports to November 6, 2020 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Oct 27, 2020 | 355 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Opening Expert Report of Jerry L. Atwood, Ph.D. Regarding Infringement of U.S. Patent No. 7,713,938 by Zydus; and (2) Expert Report of Leonard J. Chyall, Ph.D. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Oct 19, 2020 | 350 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Opening Expert Report of Dr. John Bantle filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Oct 19, 2020 | 351 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Opening Expert Report of David B. Rawlins, Ph.D. filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Oct 19, 2020 | 352 | Notice of Service (20) Docket Text: NOTICE OF SERVICE of Opening Expert Reports of Dr. James Lenhard Regarding Infringement filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Oct 19, 2020 | 353 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Opening Expert Report of Dr. Eric Parker filed by Aizant Drug Research Solutions Pvt. Ltd..(Stamoulis, Stamatios) |
| Oct 19, 2020 | 354 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Kelly E. Farnan regarding trial length. (Farnan, Kelly) |
| Oct 16, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [349] STIPULATION TO EXTEND TIME to Serve Expert Reports (Annora Pharma Private Ltd. only) to Various Dates (See stipulation) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 10/16/2020. (fms) |
| Oct 15, 2020 | 348 | SO ORDERED (4) Docket Text: SO ORDERED, re [345] STIPULATION and Proposed Order Regarding Infringement of Certain Asserted Claims between Plaintiffs and Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 10/15/2020. (nmf) |
| Oct 15, 2020 | 349 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Serve Expert Reports (Annora Pharma Private Ltd. only) to Various Dates (See stipulation) - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Oct 14, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [346] STIPULATION TO EXTEND TIME for Plaintiffs to Serve Opening Expert Reports on Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited to October 26, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 10/14/2020. (nmf) |
| Oct 9, 2020 | 345 | Stipulation (4) Docket Text: STIPULATION and Proposed Order Regarding Infringement of Certain Asserted Claims between Plaintiffs and Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Oct 9, 2020 | 346 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to Serve Opening Expert Reports on Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited to October 26, 2020 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Oct 9, 2020 | 347 | Redacted Document (6) Docket Text: REDACTED VERSION of [342] Letter by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Phillips, John) |
| Oct 8, 2020 | 344 | Main Document (6) Docket Text: REDACTED VERSION of [340] Letter by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1-9, # (2) Text of Proposed Order)(Dellinger, Megan) |
| Oct 8, 2020 | 344 | Exhibit 1-9 (25) |
| Oct 8, 2020 | 344 | Text of Proposed Order (2) |
| Oct 6, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Dispute Telephone Conference held on 10/6/2020. (Court Reporter V. Gunning.) (lih) |
| Oct 6, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER- re [335] Joint MOTION for Teleconference to Resolve Discovery Dispute The transcript of the discovery dispute teleconference held on 10/6/2020 shall serve as the order of the court. Ordered by Judge Sherry R. Fallon on 10/6/2020. (lih) |
| Oct 6, 2020 | 343 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Amended Fourth Set of Common Interrogatories to Plaintiffs (Nos. 14-20) filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Oct 1, 2020 | 341 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Lijie Wang on October 9, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Sep 21, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [336] MOTION for Pro Hac Vice Appearance of Attorney Jessica Lam and Tasha Francis Gerasimow filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 9/21/2020. (fms) |
| Sep 17, 2020 | 336 | Motion for Leave to Appear Pro Hac Vice (14) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jessica Lam and Tasha Francis Gerasimow - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Sep 17, 2020 | 337 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Rashmi Shetty on September 23, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Sep 17, 2020 | 338 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Venkat Reddy on September 25, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Sep 17, 2020 | 339 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Kishore Velaga on September 29, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Sep 14, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [335] Joint MOTION for Teleconference to Resolve Discovery Dispute. A Telephone Conference is set for 10/6/2020 at 11:00 AM before Judge Sherry R. Fallon. In preparation for this hearing the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Set Deadlines: (Moving Submission due by no later than 11:00 AM on 10/1/2020, Responsive submission due by no later than 11:00 AM on 10/2/2020.) Signed by Judge Sherry R. Fallon on 9/14/2020. (lih) |
| Sep 14, 2020 | 335 | Motion for Hearing (3) Docket Text: Joint MOTION for Teleconference to Resolve Discovery Dispute - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. Motions referred to Sherry R. Fallon.(Egan, Brian) Modified on 9/14/2020 (lih). |
| Sep 11, 2020 | 334 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Tom Versosky on September 22, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Sep 9, 2020 | 332 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Ujwal Chhabra on September 24, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Sep 9, 2020 | 333 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Arun Kumar Pandey on September 17, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Sep 8, 2020 | 330 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Fourth Set of Common Interrogatories to Plaintiffs (Nos. 14-20) filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Sep 8, 2020 | 331 | Redacted Document (4) Docket Text: REDACTED VERSION of [325] Stipulation by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Sep 3, 2020 | 327 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT as to Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. Signed by Judge Colm F. Connolly on 9/2/2020. (nmf) |
| Sep 3, 2020 | 329 | SO ORDERED (4) Docket Text: SO ORDERED, re [326] STIPULATION and Order to Modify Deadlines filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Set/Reset Scheduling Order Deadlines: ( Opening Expert Reports due by 10/16/2020., Rebuttal Expert Reports due by 12/16/2020., Expert Discovery due by 2/26/2021.) Signed by Judge Colm F. Connolly on 9/3/2020. (nmf) |
| Sep 2, 2020 | 326 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order to Modify Deadlines by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Aug 31, 2020 | 324 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Vijay Joguparthi on September 9, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Aug 28, 2020 | 323 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Aug 27, 2020 | 322 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Hyun Min Han as co-counsel. Reason for request: No longer with Winston & Strawn LLP. (Bilson, David) |
| Aug 25, 2020 | 321 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Non-infringement Contentions filed by Annora Pharma Private Limited, Hetero USA Inc..(Capuzzi, Kevin) |
| Aug 24, 2020 | 320 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Gargi Nadkarni on August 28, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Aug 21, 2020 | 319 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Brandon Ryan Harper on behalf of Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Harper, Brandon) |
| Aug 19, 2020 | 316 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Michael Mark Pursuant to Federal Rule of Civil Procedure 30(b)(1) on August 25, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Aug 19, 2020 | 317 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Frank Himmelsbach Pursuant to Federal Rule of Civil Procedure 30(b)(1) on August 28, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Aug 19, 2020 | 318 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Uli Christian Broedl Pursuant to Federal Rule of Civil Procedure 30(b)(1) on August 21, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Aug 13, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Per request of filer, the docket text of D.I. [311] has been corrected to reflect the two filers, Mankind Pharma Ltd and LifeStar Pharma LLC. (fms) |
| Aug 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [314] Stipulation filed by Laurus Labs Ltd., Laurus Generics Inc.. Ordered by Judge Colm F. Connolly on 8/13/2020. (fms) |
| Aug 13, 2020 | 315 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s [CONFIDENTIAL] Objections and Responses to Plaintiffs' Requests for Admission (1-34) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Bilson, David) |
| Aug 12, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [307] STIPULATION TO EXTEND TIME for Defendants Annora and Hetero serve final response to Plaintiffs infringement contentions to August 25, 2020 filed by Annora Pharma Private Limited, Hetero USA Inc. Signed by Judge Colm F. Connolly on 8/12/2020. (fms) |
| Aug 12, 2020 | 314 | Stipulation (3) Docket Text: STIPULATION and [Proposed Order] Regarding Infringement of Certain Asserted Claims by Laurus Generics Inc., Laurus Labs Ltd.. (Poff, Adam) |
| Aug 11, 2020 | 304 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. Xiaodi Guo on August 25, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Aug 11, 2020 | 305 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Sun's Noninfringement Contentions for its ANDA Products Associated with ANDA Nos. 212339 and 212343 for U.S. Patent Nos. 8,551,957, 9,949,998 and 10,258,637; (2) Lupin's Noninfringement Contentions for its ANDA Products Associated with ANDA Nos. 212331, 212335, and 213654 for U.S. Patent Nos. 8,551,957, 9,949,998 and 10,258,637; (3) MSN's Noninfringment Contentions For Its ANDA Products Associated with ANDA Nos. 212359, 212358, and 212362 for U.S. Patent Nos. 8,551,957, 9,949,998 and 10,258,637; (4) InvaGen's Noninfringement Contentions for its ANDA Product Associated with ANDA No. 212330 for U.S. Patent Nos. 9,949,998 and 10,258,637; (5) DRL'S Noninfringement Contentions for its ANDA Product Associated With ANDA No. 212336 For U.S. Patent Nos. 7,713,938, 9,949,998, and 10,258,637; (6) Cipla's Noninfringement Contentions for its ANDA Product Associated with ANDA No. 212243 for U.S. Patent Nos. 9,949,998 and 10,258,637 filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc..(Bilson, David) |
| Aug 11, 2020 | 306 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of V. Naga Prasad on August 21, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Aug 11, 2020 | 307 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants Annora and Hetero serve final response to Plaintiffs infringement contentions to August 25, 2020 - filed by Annora Pharma Private Limited, Hetero USA Inc.. (Torrice, Noelle) |
| Aug 11, 2020 | 308 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Non-Infringement Contentions and Responses for ANDA Products Described in ANDA No. 212382 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637 and Non-Infringement Contentions and Responses for ANDA Products Described in ANDA No. 212366 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637 filed by Alkem Laboratories Ltd..(Ormerod, Eve) |
| Aug 11, 2020 | 309 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.'s Disclosure of Noninfringement Contentions filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Farnan, Kelly) |
| Aug 11, 2020 | 310 | Notice of Service (22) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Validity Contentions filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Aug 11, 2020 | 311 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Mankind Pharma Ltd.'s and Lifestar Pharma LLC's Final Responses to Plaintiff's Infringement Contentions filed by Mankind Pharm Ltd. and Lifestar Pharma LLC. (Orlacchio, Adam) Modified on 8/13/2020 (fms). |
| Aug 11, 2020 | 312 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Final Response to Plaintiffs Infringement Contentions Against Aizant for Its ANDA Product Associated with ANDA No. 212264 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637 filed by Aizant Drug Research Solutions Pvt. Ltd..(Stamoulis, Stamatios) |
| Aug 11, 2020 | 313 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Final Response to Plaintiffs Infringement Contentions Against Prinston for Its ANDA Product Associated with ANDA No. 212264 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637 filed by Prinston Pharmaceutical Inc..(Stamoulis, Stamatios) |
| Aug 7, 2020 | 302 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Pramod Dahibhate on August 20, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Aug 7, 2020 | 303 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Jason Gensburger on August 13, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Aug 5, 2020 | 301 | Redacted Document (3) Docket Text: REDACTED VERSION of [300] Stipulation by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jul 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [300] SEALED Stipulation filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 7/30/2020. (fms) |
| Jul 27, 2020 | 299 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Rahul Dabre on July 29, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jul 23, 2020 | 297 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Rohit Mathur on July 31, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Jul 23, 2020 | 298 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Sreeraj Macha on July 31, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Jul 22, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [296] MOTION for Pro Hac Vice Appearance of Attorney Ricardo Camposanto filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 7/22/2020. (nmf) |
| Jul 22, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ricardo S. Camposanto for Cadila Healthcare Limited and Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Jul 22, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [295] STIPULATION and [Proposed] Order Regarding Infringement of Certain Asserted Claims as to Alembic filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 7/22/2020. (nmf) |
| Jul 22, 2020 | 296 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ricardo Camposanto - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # (1) Camposanto Pro Hac Certification)(Bilson, David) |
| Jul 22, 2020 | 296 | Camposanto Pro Hac Certification (1) |
| Jul 21, 2020 | 295 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Infringement of Certain Asserted Claims as to Alembic by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jul 16, 2020 | 294 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Zydus and Cadila's Objections and Responses to Plaintiffs' Requests for Admission Nos. 1-26 filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Jul 13, 2020 | 293 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Amit Bansal on July 27, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jul 8, 2020 | 292 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Kesavan Govindarajan on July 30, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jul 7, 2020 | 291 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus's [HIGHLY CONFIDENTIAL] First Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants filed by Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Jul 2, 2020 | 290 | Notice of Service (22) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' Requests for Admission (Nos. 1-33) and (2) Plaintiffs' Responses and Objections to Defendants' Third Set of Common Interrogatories to Plaintiffs (Nos. 10-13) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jun 26, 2020 | 288 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Dr. Kondal Reddy Bairy on July 8, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jun 26, 2020 | 289 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Mankind Pharma Ltd. and Lifestar Pharma LLC's Objections and Responses to Plaintiffs Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) filed by Lifestar Pharma LLC, Mankind Pharma Ltd..(Orlacchio, Adam) |
| Jun 22, 2020 | 287 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s First Set of Individual Interrogatories to Plaintiffs (No. 1) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jun 19, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [284] STIPULATION TO EXTEND TIME for Certain Deadlines to Various Dates (See Stipulation) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Set/Reset Scheduling Order Deadlines: ( Fact Discovery completed by 7/31/2020., Expert Discovery due by 2/18/2021.) Signed by Judge Colm F. Connolly on 6/19/2020. (nmf) |
| Jun 19, 2020 | 285 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Christine Walton on June 23, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jun 19, 2020 | 286 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Shobha Reddy on June 26, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jun 18, 2020 | 284 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for Certain Deadlines to Various Dates (See Stipulation) - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jun 12, 2020 | 283 | Notice of Service (22) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jun 11, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [282] Stipulation, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 6/11/2020. (fms) |
| Jun 10, 2020 | 282 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding Infringement of Certain Asserted Claims as to Aurobindo by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jun 3, 2020 | 281 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Stephanie S. Riley on behalf of Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Riley, Stephanie) |
| Jun 2, 2020 | 278 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Requests for Admission (Nos. 1-34) to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jun 2, 2020 | 279 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Requests for Admission (Nos. 1-26) to Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jun 2, 2020 | 280 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Defendants' First Set of Joint Requests for Admissions (Nos. 1-33) to Plaintiffs, and 2) Defendants' Third Set of Common Interrogatories (Nos. 10-13) to Plaintiffs filed by Laurus Generics Inc., Laurus Labs Ltd..(Poff, Adam) |
| Jun 1, 2020 | 277 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of DRL's Objections and Responses to Plaintiffs' Second Set of Requests for Production of Documents and Things (Nos. 1-4) to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Bilson, David) |
| May 22, 2020 | 276 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc.'s First Set of Individual Interrogatories to Plaintiffs (No. 1) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Bilson, David) |
| May 19, 2020 | 275 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Noelle Briana Torrice on behalf of Annora Pharma Private Limited, Hetero USA Inc. (Torrice, Noelle) |
| May 18, 2020 | 274 | Objections (11) Docket Text: ANSWER TO COUNTERCLAIMS by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. Plaintiffs' Answer to Defendant Annora Pharma Private Ltd.'s Counterclaims. (Dellinger, Megan) Modified on 5/19/2020 (fms). |
| May 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [267] MOTION for Pro Hac Vice Appearance of Attorney Alina Afinogenova and Matthew A. Lembo filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 5/15/2020. (fms) |
| May 15, 2020 | 267 | Motion for Leave to Appear Pro Hac Vice (15) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alina Afinogenova and Matthew A. Lembo - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| May 15, 2020 | 268 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Nagi Reddy Alla on June 16, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 15, 2020 | 269 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Sanjay Desai on June 12, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 15, 2020 | 270 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Kiran Kumar Doniparthi on June 18, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 15, 2020 | 271 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Mayur Gurjar on June 11, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 15, 2020 | 272 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Amarnath Reddy Lekkala on June 15, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 15, 2020 | 273 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of N.M. Sekhar on June 17, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 250 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Infringement Contentions Against Macleods for Its ANDA Products Associated with ANDA No. 212375 for U.S. Patent Nos. 7,713,938, 8,551,957, 9,949,998, and 10,258,637; (2) Plaintiffs' Infringement Contentions Against Macleods for Its ANDA Products Associated with ANDA No. 212373 for U.S. Patent Nos. 7,713,938 and 10,258,637; and (3) Plaintiffs' Infringement Contentions Against Macleods for Its ANDA Product Associated with ANDA No. 212372 for U.S. Patent Nos. 7,713,938, 8,551,957, 9,949,998, and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 251 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Infringement Contentions Against Alembic for Its ANDA Product Associated with ANDA No. 212394 for U.S. Patent Nos. 7,713,938 and 10,258,637; (2) Plaintiffs' Infringement Contentions Against Alembic for Its ANDA Products Associated with ANDA No. 212354 for U.S. Patent Nos. 9,949,998, and 10,258,637; and (3) Plaintiffs' Infringement Contentions Against Alembic for Its ANDA Product Associated with ANDA No. 212355 for U.S. Patent Nos. 9,949,998, and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 252 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Infringement Contentions Against Alkem for Its ANDA Products Associated with ANDA No. 212366 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637; and (2) Plaintiffs' Infringement Contentions Against Alkem for Its ANDA Product Associated with ANDA No. 212382 for U.S. Patent Nos. 8,551,957, 9,949,998 and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 253 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Infringement Contentions Against Prinston for Its ANDA Products Associated with ANDA No. 212264 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 254 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Infringement Contentions Against Mankind for Its ANDA Product Associated with ANDA No. 212283 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 255 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Invalidity Contentions filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| May 13, 2020 | 256 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Infringement Contentions Against Cipla for Its ANDA Product Associated with ANDA No. 212243 for U.S. Patent Nos. 9,949,998 and 10,258,637; and (2) Plaintiffs' Infringement Contentions Against Invagen for Its ANDA Product Associated with ANDA No. 212330 for U.S. Patent Nos. 9,949,998 and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 257 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Amended Invalidity Contentions Pursuant to Paragraph 4(d) Concerning U.S. Patent No. 7,579,449 filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| May 13, 2020 | 258 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Infringement Contentions Against Laurus for Its ANDA Product Associated with ANDA No. 212421 for U.S. Patent Nos. 7,579,449, 9,949,998, and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 259 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Infringement Contentions Against Aizant for Its ANDA Product Associated with ANDA No. 212322 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 260 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Infringement Contentions Against Annora for Its ANDA Products Associated with ANDA No. 212364 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637; and (2) Plaintiffs' Infringement Contentions Against Annora for Its ANDA Product Associated with ANDA No. 212365 for U.S. Patent Nos. 8,551,957, 9,949,998 and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 261 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Infringement Contentions Against Sun for Its ANDA Product Associated with ANDA No. 212343 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637; and (2) Plaintiffs' Infringement Contentions Against Sun for Its ANDA Products Associated with ANDA No. 212330 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 262 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Infringement Contentions Against Lupin for Its ANDA Products Associated with ANDA No. 213654 for U.S. Patent Nos. 9,949,998 and 10,258,637; (2) Plaintiffs' Infringement Contentions Against Lupin for Its ANDA Product Associated with ANDA No. 212331 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637; and (3) Plaintiffs' Infringement Contentions Against Lupin for Its ANDA Products Associated with ANDA No. 212335 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 263 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Infringement Contentions Against MSN for Its ANDA Products Associated with ANDA No. 212359 for U.S. Patent Nos. 8,551,957, 9,949,998, and 10,258,637; (2) Plaintiffs' Infringement Contentions Against MSN for Its ANDA Product Associated with ANDA No. 212362 for U.S. Patent Nos. 9,949,998 and 10,258,637; and (3) Plaintiffs' Infringement Contentions Against MSN for Its ANDA Product Associated with ANDA No. 212358 for U.S. Patent Nos. 9,949,998 and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 264 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Infringement Contentions Against Aurobindo for Its ANDA Products Associated with ANDA No. 212349 for U.S. Patent Nos. 7,713,938, 9,949,998, and 10,258,637; (2) Plaintiffs' Infringement Contentions Against Aurobindo for Its ANDA Product Associated with ANDA No. 212371 for U.S. Patent Nos. 7,713,938, 9,949,998, and 10,258,637; (3) Plaintiffs' Infringement Contentions Against Aurobindo for Its ANDA Products Associated with ANDA No. 212370 for U.S. Patent Nos. 7,713,938, 8,551,957, 9,949,998, and 10,258,637; and (4) Plaintiffs' Infringement Contentions Against Aurobindo for Its ANDA Products Associated with ANDA No. 212374 for U.S. Patent Nos. 7,713,938 and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 265 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Infringement Contentions Against DRL for Its ANDA Product Associated with ANDA No. 212336 for U.S. Patent Nos. 7,713,938, 9,949,998, and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 13, 2020 | 266 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Infringement Contentions Against Zydus for Its ANDA Product Associated with ANDA No. 212198 for U.S. Patent Nos. 7,579,449, 7,713,938, and 10,258,637; (2) Plaintiffs' Infringement Contentions Against Zydus for Its ANDA Product Associated with ANDA No. 213345 for U.S. Patent Nos. 7,579,449, 7,713,938, 8,551,957, 9,949,998, and 10,258,637; and (3) Plaintiffs' Infringement Contentions Against Zydus for Its ANDA Product Associated with ANDA No. 212138 for U.S. Patent Nos. 7,579,449, 7,713,938, 9,949,998, and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 7, 2020 | 249 | Notice of Substitution of Counsel (4) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Laurus Generics Inc., Laurus Labs Ltd.: Entry of appearance of attorney Adam Wyatt Poff. Attorney Damien N. Tancredi and the law firm of Flaster Greenberg terminated. (Poff, Adam) |
| May 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (9 in 1:20-cv-00277-CFC, 248 in 1:18-cv-01689-CFC-SRF) STIPULATION AND ORDER OF CONSOLIDATION. Signed by Judge Colm F. Connolly on 5/5/2020. Associated Cases: 1:18-cv-01689-CFC-SRF, 1:20-cv-00277-CFC(nmf) |
| May 5, 2020 | 248 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Apr 28, 2020 | N/A | Add Corporate Affiliates/Parents (0) Docket Text: Corporate Affiliates/Parents added per Disclosure Statement: identifying Nanomi B.V. for Lupin Pharmaceuticals, Inc. (fms) |
| Apr 28, 2020 | 247 | Disclosure Statement (2) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited, Corporate Parent Lupin Inc. for Lupin Pharmaceuticals, Inc. filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Apr 21, 2020 | 246 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Jonathan M. Knowles as co-counsel. Reason for request: No Longer Affiliated with the case. (Bilson, David) |
| Apr 17, 2020 | 244 | Redacted Document (3) Docket Text: REDACTED VERSION of [240] Stipulation of Dismissal of U.S. Patent No. 7,713,938 by Alkem Laboratories Ltd.. (Ormerod, Eve) |
| Apr 17, 2020 | 245 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus's Objections and Responses to Plaintiffs' Third Set of Requests for Production of Documents and Things (Nos. 1-4) to Zydus Pharmaceuticals (USA), Inc. and Cadila Healthcare Limited filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Apr 16, 2020 | 243 | Notice to Take Deposition (19) Docket Text: NOTICE to Take Deposition of Plaintiffs Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GMBH, and Boehringer Ingelheim Corporation on June 5, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Apr 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [240] SEALED Stipulation of Dismissal of U.S. Patent No. 7,713,938 filed by Alkem Laboratories Ltd. Ordered by Judge Colm F. Connolly on 4/13/2020. (fms) |
| Apr 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [241] STIPULATION TO EXTEND TIME. Setting Scheduling Order Deadlines : Amended Pleadings due by 6/15/2020., Joinder of Parties due by 6/15/2020. Fact Discovery completed by 7/2/2020., Opening Expert Reports due by 8/28/2020., Rebuttal Expert Reports due by 10/30/2020., Reply Expert Reports due by 12/7/2020., Expert Discovery due by 1/18/2021. See stipulation for additional details and deadlines. Ordered by Judge Colm F. Connolly on 4/13/2020. (fms) |
| Apr 13, 2020 | 242 | Notice of Service (21) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendants' Second Set of Common Interrogatories to Plaintiffs (No. 9), and (2) Plaintiffs' Responses and Objections to Defendants' Third Set of Requests for the Production of Documents and Things (No. 69) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Apr 10, 2020 | 239 | Main Document (7) Docket Text: NOTICE of Notice of Subpoenas to Eli Lilly & Company by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc. (Attachments: # (1) Exhibit 1 - 2)(Bilson, David) |
| Apr 10, 2020 | 239 | Exhibit 1 - 2 (12) |
| Apr 10, 2020 | 241 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME Various Scheduling Order Dates to See Stipulation - filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc.. (Phillips, John) |
| Apr 7, 2020 | 238 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Sun Pharmaceuticals Industries Ltd. and Sun Pharmaceutical Industries, Inc.'s [CONFIDENTIAL] Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants; (2) Defendants Cipla Limited and Cipla USA, Inc.'s [CONFIDENTIAL] Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants; (3) Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s [CONFIDENTIAL] Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants; (4) Defendant Invagen Pharmaceuticals, Inc.'s [CONFIDENTIAL] Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants; (5) Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s [CONFIDENTIAL] Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants; and (6) Defendants MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc.'s [CONFIDENTIAL] Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc..(Bilson, David) |
| Apr 2, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael K. Nutter for Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Apr 1, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [234] STIPULATION TO EXTEND TIME Substantial Completion of Document Production and Due Date for Plaintiffs to serve final infringement contentions to April 30, 2020 and May 13, 2020 filed by Aizant Drug Research Solutions Pvt. Ltd., [235] STIPULATION TO EXTEND TIME Substantial Completion of Document Production and Due Date for Plaintiffs to serve final infringement contentions to April 24, 2020 and May 13, 2020 filed by Prinston Pharmaceutical Inc. Ordered by Judge Colm F. Connolly on 4/1/2020. (fms) |
| Apr 1, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Eric D. Dunbar for Cadila Healthcare Limited, for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Apr 1, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [237] MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales and James F. Hurst filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 4/1/2020. (fms) |
| Apr 1, 2020 | 236 | Notice Requesting Removal of Co-Counsel (12) Docket Text: NOTICE requesting Clerk to remove Leora Ben-Ami as co-counsel. Reason for request: no longer on case. (Dellinger, Megan) |
| Apr 1, 2020 | 237 | Motion for Leave to Appear Pro Hac Vice (15) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales and James F. Hurst - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Mar 31, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [233] MOTION for Pro Hac Vice Appearance of Attorney Eric D. Dunbar filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 3/31/2020. (fms) |
| Mar 31, 2020 | 233 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Eric D. Dunbar - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # (1) Dunbar Pro Hac Certification)(Bilson, David) |
| Mar 31, 2020 | 233 | Dunbar Pro Hac Certification (1) |
| Mar 31, 2020 | 234 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME Substantial Completion of Document Production and Due Date for Plaintiffs to serve final infringement contentions to April 30, 2020 and May 13, 2020 - filed by Aizant Drug Research Solutions Pvt. Ltd.. (Stamoulis, Stamatios) |
| Mar 31, 2020 | 235 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME Substantial Completion of Document Production and Due Date for Plaintiffs to serve final infringement contentions to April 24, 2020 and May 13, 2020 - filed by Prinston Pharmaceutical Inc.. (Stamoulis, Stamatios) |
| Mar 26, 2020 | 232 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Sun Pharmaceuticals Industries Ltd. and Sun Pharmaceutical Industries, Inc.'s Objections and Response to Plaintiffs' Notice of Deposition of Sun Pursuant to Fed. R. Civ. P. 30(b)(6); (2) Defendants Cipla Limited and Cipla USA, Inc.'s Objections and Response to Plaintiffs' Notice of Deposition of Cipla Pursuant to Fed. R. Civ. P. 30(b)(6); (3) Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Objections and Response to Plaintiffs' Notice of Deposition of DRL Pursuant to Fed. R. Civ. P. 30(b)(6); (4) Defendant Invagen Pharmaceuticals, Inc.'s Objections and Response to Plaintiffs' Notice of Deposition of Invagen Pursuant to Fed. R. Civ. P. 30(b)(6); (5) Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Objections and Response to Plaintiffs' Notice of Deposition of Lupin Pursuant to Fed. R. Civ. P. 30(b)(6); and (6) Defendants MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc.'s Objections and Response to Plaintiffs' Notice of Deposition of MSN Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc..(Bilson, David) |
| Mar 24, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jason Z. Pesick for Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, and Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Mar 24, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sarah A. Krajewski for Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Mar 23, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [230] MOTION for Pro Hac Vice Appearance of Attorney Jason Z. Pesick and Sarah A. Krajewski filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Lupin Pharmaceuticals, Inc., MSN Pharmaceuticals Inc., Cipla Limited, Cipla USA, Inc., InvaGen Pharmaceuticals, Inc., MSN Laboratories Private Ltd., Lupin Ltd. Signed by Judge Colm F. Connolly on 3/23/2020. (nmf) |
| Mar 23, 2020 | 229 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Ryan B. Hauer as co-counsel. Reason for request: No Longer Affiliated with the case. (Bilson, David) |
| Mar 23, 2020 | 230 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jason Z. Pesick and Sarah A. Krajewski - filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Attachments: # (1) Certification of Jason Z. Pesick, # (2) Certification of Sarah A. Krajewski)(Bilson, David) |
| Mar 23, 2020 | 230 | Certification of Jason Z. Pesick (1) |
| Mar 23, 2020 | 230 | Certification of Sarah A. Krajewski (1) |
| Mar 23, 2020 | 231 | Notice of Service (21) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Second Set of Requests for the Production of Documents and Things (No. 68) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Mar 20, 2020 | 216 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Martin Schuehle on May 28, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 20, 2020 | 217 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Frank Himmelsbach on May 18, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 20, 2020 | 218 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Matthias Eckhardt on May 19, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 20, 2020 | 219 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Sandra Schmid on May 27, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 20, 2020 | 220 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Hans-Jurgen Woerle on June 4, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 20, 2020 | 221 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Klaus Dugi on May 21, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 20, 2020 | 222 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Michael Mark on May 26, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 20, 2020 | 223 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Leo Thomas on May 20, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 20, 2020 | 224 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Uli Christian Broedl on June 1, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 20, 2020 | 225 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Sreeraj Macha on June 2, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 20, 2020 | 226 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Hans-Jurgen Martin on May 29, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 20, 2020 | 227 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Maximilian Von Eynatten on June 3, 2020 filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 20, 2020 | 228 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Edward Leon Barsoumian on May 22, 2020 filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 18, 2020 | 215 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Third Set of Requests for Production of Documents and Things (Nos. 1-4) to Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited; and (2) Plaintiffs' Second Set of Requests for Production of Documents and Things (Nos. 1-4) to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Mar 16, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [213] Joint STIPULATION TO EXTEND TIME to Substantially Complete Document Production to March 31, 2020 filed by Aizant Drug Research Solutions Pvt. Ltd., [214] Joint STIPULATION TO EXTEND TIME to Substantially Complete Document Production to March 31, 2020 filed by Prinston Pharmaceutical Inc. Signed by Judge Colm F. Connolly on 3/16/2020. (fms) |
| Mar 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [212] STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to March 31, 2020 filed by Annora Pharma Private Limited, Hetero USA Inc., [211] STIPULATION TO EXTEND TIME re: Substantial Completion of Document Production to March 31, 2020 filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 3/13/2020. (nmf) |
| Mar 13, 2020 | 211 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME re: Substantial Completion of Document Production to March 31, 2020 - filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Farnan, Kelly) |
| Mar 13, 2020 | 212 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to March 31, 2020 - filed by Annora Pharma Private Limited, Hetero USA Inc.. (Harmon, Kate) |
| Mar 13, 2020 | 213 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to Substantially Complete Document Production to March 31, 2020 - filed by Aizant Drug Research Solutions Pvt. Ltd.. (Stamoulis, Stamatios) |
| Mar 13, 2020 | 214 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to Substantially Complete Document Production to March 31, 2020 - filed by Prinston Pharmaceutical Inc.. (Stamoulis, Stamatios) |
| Mar 11, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [209] STIPULATION TO EXTEND TIME March 13, 2020 to March 31,2020 filed by Laurus Labs Ltd., Laurus Generics Inc. Signed by Judge Colm F. Connolly on 3/11/2020. (fms) |
| Mar 11, 2020 | 209 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME March 13, 2020 to March 31,2020 - filed by Laurus Generics Inc., Laurus Labs Ltd.. (Tancredi, Damien) |
| Mar 11, 2020 | 210 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Joint Third Requests for Production of Documents and Things (No. 69) to Plaintiffs; and (2) Defendants' Second Set of Common Interrogatories to Plaintiffs (No. 9) filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 6, 2020 | 208 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus's Objections and Responses to Plaintiffs' Notice of Deposition of Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Feb 27, 2020 | 206 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Alkem Laboratories Ltd..(Ormerod, Eve) |
| Feb 27, 2020 | 207 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Annora Pharma Private Ltd. And Hetero USA Inc.s Responses and Objections to Plaintiffs Notice of Rule 30(b)(6) Deposition filed by Annora Pharma Private Limited, Hetero USA Inc..(Harmon, Kate) |
| Feb 26, 2020 | 205 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Laurus Generics Inc., Laurus Labs Ltd..(Tancredi, Damien) |
| Feb 23, 2020 | 203 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Objections to Plaintiffs Notice of Deposition filed by Prinston Pharmaceutical Inc..(Stamoulis, Stamatios) |
| Feb 23, 2020 | 204 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Objections to Plaintiffs Notice of Deposition filed by Aizant Drug Research Solutions Pvt. Ltd..(Stamoulis, Stamatios) |
| Feb 21, 2020 | 202 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Joint Second Requests for Production of Documents and Things (No. 68) to Plaintiffs filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Feb 12, 2020 | 201 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to FRCP 30(b)(6) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Connolly, Arthur) |
| Feb 6, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Karen L. Beckman for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Feb 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [197] STIPULATION TO EXTEND TIME for Various Scheduling Order Dates to See Stipulation filed by Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Lupin Pharmaceuticals, Inc., MSN Pharmaceuticals Inc., Cipla Limited, Cipla USA, Inc., InvaGen Pharmaceuticals, Inc., MSN Laboratories Private Ltd., Lupin Ltd., Cadila Healthcare Limited, ORDER, Setting Deadlines: ( Fact Discovery completed by 6/5/2020.) Signed by Judge Colm F. Connolly on 2/5/2020. (nmf) |
| Feb 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [198] MOTION for Pro Hac Vice Appearance of Attorney Karen Beckman filed by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc. Signed by Judge Colm F. Connolly on 2/5/2020. (nmf) |
| Feb 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [199] MOTION for Pro Hac Vice Appearance of Attorney Leora Ben-Ami, Jeanna M. Wacker, Mira A. Mulvaney, Christopher T. Jagoe, Thomas F. Fleming, Sam Kwon, Ashley Ross and Christopher J. Citro filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 2/5/2020. (nmf) |
| Feb 5, 2020 | 199 | Motion for Leave to Appear Pro Hac Vice (21) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Leora Ben-Ami, Jeanna M. Wacker, Mira A. Mulvaney, Christopher T. Jagoe, Thomas F. Fleming, Sam Kwon, Ashley Ross and Christopher J. Citro - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Feb 5, 2020 | 200 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Objections to Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Farnan, Kelly) |
| Feb 4, 2020 | 197 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME for Various Scheduling Order Dates to See Stipulation - filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc.. (Phillips, John) |
| Feb 4, 2020 | 198 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Karen Beckman - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Farnan, Kelly) |
| Jan 22, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Notices of Deposition previously found at D.I. 187 and D.I. 190-195 have been deleted as they listed an incorrect date. Corrected versions will be re-filed soon. (nmf) |
| Jan 22, 2020 | 180 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Mankind Pharma Ltd. and Lifestar Pharma LLC on March 5, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jan 22, 2020 | 181 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. on February 24, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jan 22, 2020 | 182 | Notice to Take Deposition (10) Docket Text: NOTICE to Take Deposition of Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited on February 19, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jan 22, 2020 | 183 | Notice to Take Deposition (10) Docket Text: NOTICE to Take Deposition of Cipla Limited and Cipla USA, Inc. on February 28, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jan 22, 2020 | 184 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Prinston Pharmaceutical Inc. on March 9, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jan 22, 2020 | 185 | Notice to Take Deposition (10) Docket Text: NOTICE to Take Deposition of Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. on February 25, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jan 22, 2020 | 186 | Notice to Take Deposition (10) Docket Text: NOTICE to Take Deposition of Annora Pharma Private Limited and Hetero USA Inc. on February 27, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jan 22, 2020 | 188 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Laurus Labs Ltd. and Laurus Generics Inc. on March 3, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jan 22, 2020 | 189 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Lupin Ltd. and Lupin Pharmaceuticals, Inc. on March 4, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jan 22, 2020 | 190 | Notice to Take Deposition (10) Docket Text: NOTICE to Take Deposition of Invagen Pharmaceuticals, Inc. on March 2, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) Modified on 1/23/2020 (nmf). |
| Jan 22, 2020 | 191 | Notice to Take Deposition (10) Docket Text: NOTICE to Take Deposition of Alkem Laboratories Ltd. on February 21, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) Modified on 1/23/2020 (nmf). |
| Jan 22, 2020 | 192 | Notice to Take Deposition (10) Docket Text: NOTICE to Take Deposition of Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. on February 18, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.(Dellinger, Megan) Modified on 1/23/2020 (nmf). |
| Jan 22, 2020 | 193 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. on March 6, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) Modified on 1/23/2020 (nmf). |
| Jan 22, 2020 | 194 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Aizant Drug Research Solutions Pvt. Ltd. on February 26, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) Modified on 1/23/2020 (nmf). |
| Jan 22, 2020 | 195 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc. on March 10, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) Modified on 1/23/2020 (nmf). |
| Jan 22, 2020 | 196 | Notice to Take Deposition (10) Docket Text: NOTICE to Take Deposition of Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc. on February 20, 2020 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) Modified on 1/23/2020 (nmf). |
| Jan 13, 2020 | 179 | Notice of Service (21) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' First Set of Interrogatories (Nos. 1-8) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Dec 27, 2019 | 177 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Damien Nicholas Tancredi on behalf of Laurus Generics Inc., Laurus Labs Ltd. (Tancredi, Damien) |
| Dec 27, 2019 | 178 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Jeremy S. Cole as co-counsel. Reason for request: Leaving Firm. (Cole, Jeremy) |
| Dec 9, 2019 | 176 | SO ORDERED (5) Docket Text: SO ORDERED, re [174] STIPULATION and Order Regarding Claim Construction re [132] Claim Construction Chart. ORDER, terminating Hearings: The 4/7/2020 Markman hearing is cancelled per this order. Signed by Judge Colm F. Connolly on 12/9/2019. (nmf) |
| Dec 6, 2019 | 174 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order Regarding Claim Construction re [132] Claim Construction Chart, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Dec 6, 2019 | 175 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding Stipulation and Proposed Order regarding Claim Construction and Markman Hearing - re [132] Claim Construction Chart, [174] Stipulation,. (Dellinger, Megan) |
| Dec 2, 2019 | 173 | Notice of Service (16) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions (directed to various defendants as outlined in notice) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Nov 22, 2019 | 172 | SO ORDERED (5) Docket Text: SO ORDERED, re [171] Stipulation and Order Dismissing Defendant Ohm Laboratories, Inc. and Amending Caption filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited, Ohm Laboratories, Inc. Party Ohm Laboratories, Inc. terminated. Signed by Judge Colm F. Connolly on 11/22/2019. (fms) |
| Nov 21, 2019 | 171 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order Dismissing Defendant Ohm Laboratories, Inc. and Amending Caption by Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Bilson, David) |
| Nov 20, 2019 | 169 | Answer to Counterclaim (22) Docket Text: ANSWER to [131] Answer to Complaint,, Counterclaim, -- Plaintiffs' Answer to Aurobindo Pharma Ltd.'s and Aurobindo Pharma USA, Inc.'s Counterclaims -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Nov 20, 2019 | 170 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.'s Answers to Plaintiffs' First Set of Interrogatories to All Defendants, (2) Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.'s Responses to Plaintiffs' First Set of Requests to All Defendants for the Production of Documents and Things and (3) Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.'s Responses to Plaintiffs' Second Set of Requests to Certain Defendants for the Production of Documents and Things filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Mosley, Renee) |
| Nov 19, 2019 | 167 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Amended Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Nov 19, 2019 | 168 | Answer to Counterclaim (21) Docket Text: ANSWER to [130] Answer to Complaint,, Counterclaim, -- Plaintiffs' Answer to Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.'s Counterclaims -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Nov 18, 2019 | 161 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Annora Pharma Private Ltd. and Hetero USA Inc.s Responses and Objections to Plaintiffs First Set of Interrogatories filed by Annora Pharma Private Limited, Hetero USA Inc..(Harmon, Kate) |
| Nov 18, 2019 | 162 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Connolly, Arthur) |
| Nov 18, 2019 | 163 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Nov 18, 2019 | 164 | Answer to Counterclaim (21) Docket Text: ANSWER to [128] Answer to Complaint, Counterclaim -- Plaintiffs' Answer to Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. Counterclaims -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Nov 18, 2019 | 165 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Defendants' Paragraph 3 Disclosures Regarding Discovery ('637 Patent Suit) filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Mosley, Renee) |
| Nov 18, 2019 | 166 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; and (2) Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) |
| Nov 15, 2019 | 159 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Verified Responses to Plaintiffs' First Set of Interrogatories filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Connolly, Arthur) |
| Nov 15, 2019 | 160 | Main Document (2) Docket Text: NOTICE OF SERVICE of Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-7) and First Set of Requests for Production (Nos. 1-74) filed by Mankind Pharma Ltd.. (Attachments: # (1) Certificate of Service)(Orlacchio, Adam) |
| Nov 15, 2019 | 160 | Certificate of Service (1) |
| Nov 14, 2019 | 158 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alkem Laboratories Ltd.'s Objections and Responses to Plaintiffs' First Set of Requests to All Defendants for the Production of Documents and Things filed by Alkem Laboratories Ltd..(Ormerod, Eve) |
| Nov 13, 2019 | 155 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Common Interrogatories to Plaintiffs (Nos. 1-8) filed by Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Nov 13, 2019 | 156 | Answer to Complaint (22) Docket Text: ANSWER to Complaint -- Answer to Lupin Ltd.'s Counterclaims -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Nov 13, 2019 | 157 | Answer to Complaint (20) Docket Text: ANSWER to Complaint -- Answer to MSN's Counterclaims -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Nov 12, 2019 | 154 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Aizant Drug Research Solutions Pvt. Ltd.s Amended Response to Plaintiffs First Set of Interrogatories filed by Aizant Drug Research Solutions Pvt. Ltd..(Stamoulis, Stamatios) |
| Nov 11, 2019 | 152 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Aizant Drug Research Solutions Pvt. Ltd.s Response to Plaintiffs First Set of Interrogatories and Defendant Aizant Drug Research Solutions Pvt. Ltd.s Response to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-74) filed by Aizant Drug Research Solutions Pvt. Ltd..(Stamoulis, Stamatios) |
| Nov 11, 2019 | 153 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Prinston Pharmaceutical Inc.s Response to Plaintiffs First Set of Interrogatories, Defendant Prinston Pharmaceutical Inc.s Response to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-74), and Defendant Prinston Pharmaceutical Inc.s Response to Plaintiffs Second Set of Requests for the Production of Documents and Things filed by Prinston Pharmaceutical Inc..(Stamoulis, Stamatios) |
| Nov 8, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [142] STIPULATION TO EXTEND TIME for Defendants to Respond to Plaintiffs' Interrogatories to November 14, 2019 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Colm F. Connolly on 11/8/2019. (fms) |
| Nov 8, 2019 | 149 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Zydus's Objections and Responses to Plaintiffs' First Set of Requests to All Defendants for the Production of Documents and Things; (2) Zydus's Objections and Responses to Plaintiffs' Second Set of Requests to Zydus Pharmaceuticals USA, Inc., Cadila Healthcare Ltd., et al. for the Production of Documents and Things; and (3) Zydus's [HIGHLY CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants filed by Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Nov 8, 2019 | 150 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Cipla's Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-74); (2) DRL's Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-74); (3) Invagen's Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-74); (4) Lupin's Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-74); (5) MSN's Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-74); (6) Sun's Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-74); (7) Invagen's Objections and Responses to Plaintiff's Second Set of Requests to Defendants Zydus Pharmaceuticals USA, Inc., Cadila Healthcare Ltd., MSN Laboratories Private Ltd., MSN Pharmaceuticals, Inc., Annora Pharma Private Ltd., Hetero USA Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Macleods Pharmaceuticals, Ltd., Macleods Pharma USA Inc., Prinston Pharmaceutical Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Laurus Labs Ltd., Laurus Generics Inc., and Invagen Pharmaceuticals, Inc. for the Production of Documents and Things; (8) Lupin's Objections and Responses to Plaintiff's Second Set of Requests to Defendants Zydus Pharmaceuticals USA, Inc., Cadila Healthcare Ltd., MSN Laboratories Private Ltd., MSN Pharmaceuticals, Inc., Annora Pharma Private Ltd., Hetero USA Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Macleods Pharmaceuticals, Ltd., Macleods Pharma USA Inc., Prinston Pharmaceutical Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Laurus Labs Ltd., Laurus Generics Inc., and Invagen Pharmaceuticals, Inc. for the Production of Documents and Things; (9) MSN's Objections and Responses to Plaintiff's Second Set of Requests to Defendants Zydus Pharmaceuticals USA, Inc., Cadila Healthcare Ltd., MSN Laboratories Private Ltd., MSN Pharmaceuticals, Inc., Annora Pharma Private Ltd., Hetero USA Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Macleods Pharmaceuticals, Ltd., Macleods Pharma USA Inc., Prinston Pharmaceutical Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Laurus Labs Ltd., Laurus Generics Inc., and Invagen Pharmaceuticals, Inc. for the Production of Documents and Things; (10) Defendants MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.'s [CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants; (11) Defendants Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries Inc.'s [CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants; (12) Defendants Cipla Limited and Cipla USA, Inc.'s [CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants; (13) Defendants Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc.'s [CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants; (14) Defendant Invagen Pharmaceuticals Inc.'s [CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants; and (15) Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s [CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc..(Bilson, David) |
| Nov 8, 2019 | 151 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendants Annora Pharma Private Ltd. and Hetero USA Inc.s Responses and Objections to Plaintiffs First Set of Requests for the Production of Documents and Things; and (ii) Defendants Annora Pharma Private Ltd. and Hetero USA, Inc.s Responses and Objections to Plaintiffs Second Set of Requests for the Production of Documents and Things filed by Annora Pharma Private Limited, Hetero USA Inc..(Harmon, Kate) |
| Nov 7, 2019 | 141 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alkem Laboratories Ltd.'s Objections and Responses to Plaintiffs' First Set of Interrogatories to All Defendants filed by Alkem Laboratories Ltd..(Ormerod, Eve) |
| Nov 7, 2019 | 142 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Defendants to Respond to Plaintiffs' Interrogatories to November 14, 2019 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Nov 7, 2019 | 143 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd.'s Responses and Objections to Plaintiffs' First and Second Set of Requests for Production filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Connolly, Arthur) |
| Nov 7, 2019 | 144 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Responses and Objections to Plaintiffs' First Set of Interrogatories filed by Laurus Generics Inc., Laurus Labs Ltd..(Cole, Jeremy) |
| Nov 7, 2019 | 145 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Responses and Objections to Plaintiffs' First Set of Requests for Production of Documents filed by Laurus Generics Inc., Laurus Labs Ltd..(Cole, Jeremy) |
| Nov 7, 2019 | 146 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Responses and Objections to Plaintiffs' Second Set of Requests for Production of Documents filed by Laurus Generics Inc., Laurus Labs Ltd..(Cole, Jeremy) |
| Nov 7, 2019 | 147 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Supplemental Initial Disclosures filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Mosley, Renee) |
| Nov 7, 2019 | 148 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Objections and Responses to First Set of Interrogatories to all Defendants and Objections and Responses to First Set of Requests to All Defendants for the Production of Documents and Things filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Mosley, Renee) |
| Nov 6, 2019 | 139 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Aurobino Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Rule 26 Initial Disclosures filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Connolly, Arthur) |
| Nov 6, 2019 | 140 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Macleods Pharmaceuticals, Ltd. and Macleods Pharma USA, Inc.s Rule 26(a)(1) Initial Disclosures and (2) Macleods Pharmaceuticals, Ltd. and Macleods Pharma USA Inc.s Initial Disclosures Pursuant to the Delaware Default Standard, 3 filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Mosley, Renee) |
| Nov 4, 2019 | 138 | Notice of Service (21) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' First Set of Requests for the Production of Documents and Things (Nos. 1-67) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Nov 1, 2019 | 135 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a) Initial Disclosures filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Nov 1, 2019 | 136 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1); and (2) MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) filed by Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) |
| Nov 1, 2019 | 137 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Defendants' Initial Disclosures ('637 Patent Suit) filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Mosley, Renee) |
| Oct 30, 2019 | N/A | Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [134] MOTION [Defendants' Motion for Claim Construction] re [132] Claim Construction Chart, [133] MOTION for Claim Construction re [132] Claim Construction Chart. The automatic referral generated by the system has been removed for these motions. (nmf) |
| Oct 30, 2019 | 131 | Main Document (31) Docket Text: ANSWER to Complaint , Affirmative Defenses, and, COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Attachments: # (1) Exhibit A)(Connolly, Arthur) |
| Oct 30, 2019 | 131 | Exhibit A (48) |
| Oct 30, 2019 | 132 | Main Document (7) Docket Text: CLAIM Construction Chart by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1 - '938 Patent, # (2) Exhibit 2 - '938 Notice of Allowance)(Dellinger, Megan) |
| Oct 30, 2019 | 132 | Exhibit 1 - '938 Patent (11) |
| Oct 30, 2019 | 132 | Exhibit 2 - '938 Notice of Allowance (6) |
| Oct 30, 2019 | 133 | Motion for Miscellaneous Relief (14) Docket Text: MOTION for Claim Construction re [132] Claim Construction Chart, - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.(Dellinger, Megan) Modified on 11/8/2019 (nmf). |
| Oct 30, 2019 | 134 | Motion for Miscellaneous Relief (5) Docket Text: MOTION [Defendants' Motion for Claim Construction] re [132] Claim Construction Chart, - filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.(Bilson, David) Modified on 11/8/2019 (nmf). |
| Oct 29, 2019 | N/A | Remark (0) Docket Text: All papers shall be filed in C.A. No. 18-1689 (CFC) (consolidated). Associated Cases: 1:18-cv-01689-CFC-SRF et al.(fms) |
| Oct 29, 2019 | 129 | SO ORDERED (6) Docket Text: SO ORDERED, re (8 in 1:19-cv-01866-CFC, 8 in 1:19-cv-01865-CFC, 8 in 1:19-cv-01885-CFC, 8 in 1:19-cv-01864-CFC, 127 in 1:18-cv-01689-CFC-SRF, 9 in 1:19-cv-01862-CFC) Stipulation. The New Cases shall be consolidated with the Consolidated Action for all purposes, and all papers shall be filed in C.A. No. 18-1689 (CFC) (consolidated). See Stipulations for further details and deadlines. Signed by Judge Colm F. Connolly on 10/29/2019. Associated Cases: 1:18-cv-01689-CFC-SRF et al.(fms) |
| Oct 29, 2019 | 130 | Answer to Complaint (20) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals Ltd..(Farnan, Kelly) |
| Oct 28, 2019 | 128 | Answer to Complaint (15) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM of Defendants against All Plaintiffs by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc..(Farnan, Kelly) |
| Oct 21, 2019 | 127 | Stipulation (6) Docket Text: STIPULATION for Consolidation by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) |
| Oct 16, 2019 | 126 | SO ORDERED (3) Docket Text: SO ORDERED, re [123] Stipulation of Dismissal Regarding U.S. Pat. No. 9,949,997 as to Defendants Annora Pharma Private Ltd. and Hetero USA Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 10/16/2019. (fms) |
| Oct 15, 2019 | 124 | Notice of Service (21) Docket Text: NOTICE OF SERVICE of Plaintiffs' Identification of Terms Needing Construction filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Oct 15, 2019 | 125 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Proposed Claim Constructions and Intrinsic Evidence filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Oct 11, 2019 | 123 | Stipulation (3) Docket Text: STIPULATION of Dismissal Regarding U.S. Pat. No. 9,949,997 as to Defendants Annora Pharma Private Ltd. and Hetero USA Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Oct 10, 2019 | 121 | Answer to Counterclaim (10) Docket Text: ANSWER to [95] Answer to Complaint,, Counterclaim, -- Answer to Annora Pharma Private Ltd.'s Counterclaims by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Oct 10, 2019 | 122 | Answer to Counterclaim (11) Docket Text: ANSWER to [98] Answer to Complaint,, Counterclaim, -- Answer to Laurus Labs Ltd. and Laurus Generics Inc.'s Counterclaims by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Oct 8, 2019 | 117 | Notice of Service (21) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests to All Defendants for the Production of Documents and Things and (2) Plaintiffs' First Set of Interrogatories to All Defendants filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Oct 8, 2019 | 118 | Notice of Service (13) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests to Defendants Zydus Pharmaceuticals USA, Inc., Cadila Healthcare Ltd., MSN Laboratories Private Ltd., MSN Pharmaceuticals, Inc., Annora Pharma Private Ltd., Hetero USA Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Macleods Pharmaceuticals, Ltd., Macleods Pharma USA Inc., Prinston Pharmaceutical Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Laurus Labs Ltd., Laurus Generics Inc., and Invagen Pharmaceuticals, Inc. for the Production of Documents and Things filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Oct 8, 2019 | 119 | Notice of Service (21) Docket Text: NOTICE OF SERVICE of Plaintiffs' Identification of Terms Needing Construction filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Oct 8, 2019 | 120 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Identification of Claim Terms for Construction filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Mosley, Renee) |
| Oct 4, 2019 | 116 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Joint First Requests for Production for Documents and Things (Nos. 1-67) filed by Aizant Drug Research Solutions Pvt. Ltd., Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., Alkem Laboratories Ltd., Annora Pharma Private Limited, Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hetero USA Inc., InvaGen Pharmaceuticals, Inc., Laurus Generics Inc., Laurus Labs Ltd., Lifestar Pharma LLC, Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Mankind Pharma Ltd., Ohm Laboratories, Inc., Prinston Pharmaceutical Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Oct 2, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Steven J. Moore, and James E. Nealon for Aurobindo Pharma Ltd. and for Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Oct 1, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [115] MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and James E. Nealon filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Colm F. Connolly on 10/1/2019. (fms) |
| Oct 1, 2019 | 115 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and James E. Nealon - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Sep 27, 2019 | 112 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Disclosures Pursuant to FRCP 26(a)(1) and Paragraph 3 of the Delaware Default Standard for Discovery filed by Laurus Generics Inc., Laurus Labs Ltd..(Cole, Jeremy) |
| Sep 27, 2019 | 113 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,449 B2 ;7,713,938 B2 ;8,551,957 B2 ;9,949,998 B2 ;10,258,637 B2 ;9,949,997 B2 . (Dellinger, Megan) |
| Sep 27, 2019 | 114 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions for the '637 Patent filed by Aizant Drug Research Solutions Pvt. Ltd., Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., Alkem Laboratories Ltd., Annora Pharma Private Limited, Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hetero USA Inc., InvaGen Pharmaceuticals, Inc., Laurus Generics Inc., Laurus Labs Ltd., Lifestar Pharma LLC, Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Mankind Pharma Ltd., Ohm Laboratories, Inc., Prinston Pharmaceutical Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Sep 26, 2019 | N/A | Patent Report Notice (0) Docket Text: PATENT REPORT NOTICE: Please note that if patents are being added to this case by the consolidation or otherwise, the filing party should complete the Report to Commissioner of Patents & Trademarks, and enter it on the docket using the PATENT/TRADEMARK REPORT event in the OTHER DOCUMENT list. The patent report form can be found at www.ded.uscourts.gov under the Clerk's Office FORMS button. (fms) |
| Sep 26, 2019 | 110 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Annora Pharma Private Ltd.s Rule 26(a)(1) Initial Disclosures and Disclosures filed by Annora Pharma Private Limited.(Harmon, Kate) |
| Sep 26, 2019 | 111 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Hetero USA, Inc.s Rule 26(a)(1) Initial Disclosures and Disclosures pursuant to District of Delawares Default Standard for Discovery filed by Hetero USA Inc..(Harmon, Kate) |
| Sep 25, 2019 | 100 | Objections (13) Docket Text: Plaintiffs' Answer to Aizant Drug Research Solutions Pvt. Ltd.'s Counterclaims (Linked to D.I. 8 in C.A. 19-1492) -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (Egan, Brian) Modified on 9/26/2019 (fms). |
| Sep 25, 2019 | 101 | Objections (15) Docket Text: Plaintiffs' Answer to Alkem Laboratories Ltd.'s Counterclaims (Linked to D.I. 10 in C.A. 19-1493) -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (Egan, Brian) Modified on 9/26/2019 (fms). |
| Sep 25, 2019 | 102 | Objections (12) Docket Text: Plaintiffs' Answer to Defendants Cipla Limited and Cipla USA, Inc.'s Counterclaims (Linked to D.I. 9 in C.A. 19-1494) -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (Egan, Brian) Modified on 9/26/2019 (fms). |
| Sep 25, 2019 | 103 | Objections (12) Docket Text: Plaintiffs' Answer to Defendants Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc.'s Counterclaims (Linked to D.I. 9 in C.A. 19-1495) --by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (Egan, Brian) Modified on 9/26/2019 (fms). |
| Sep 25, 2019 | 104 | Objections (11) Docket Text: Plaintiffs' Answer to Defendant Invagen Pharmaceuticals, Inc.'s Counterclaims (Linked to D.I. 8 in C.A. 19-1496) --by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (Egan, Brian) Modified on 9/26/2019 (fms). |
| Sep 25, 2019 | 105 | Objections (11) Docket Text: Plaintiffs' Answer to Defendant Lupin Ltd.'s Counterclaims (Linked to D.I. 9 in C.A. 19-1497) -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (Egan, Brian) Modified on 9/26/2019 (fms). |
| Sep 25, 2019 | 106 | Objections (8) Docket Text: Plaintiffs' Answer to Defendants Mankind Pharma Ltd. and Lifestar Pharma LLC's Counterclaims (Linked to D.I. 10 in C.A. 19-1498) -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.(Egan, Brian) Modified on 9/26/2019 (fms). |
| Sep 25, 2019 | 107 | Objections (14) Docket Text: Plaintiffs' Answer to Prinston Pharmaceutical Inc.'s Counterclaims (Linked to D.I. 10 in C.A. 19-1499) by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. . (Egan, Brian) Modified on 9/26/2019 (fms). |
| Sep 25, 2019 | 108 | Objections (12) Docket Text: Plaintiffs' Answer to Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., and Ohm Laboratories, Inc.'s Counterclaims (Linked to D.I. 10 in C.A. 19-1500) by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. . (Egan, Brian) Modified on 9/26/2019 (fms). |
| Sep 25, 2019 | 109 | Objections (14) Docket Text: Plaintiffs' Answer to Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.'s Counterclaims (Linked to D.I. 9 in C.A. 19-1501) by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) Modified on 9/26/2019 (fms). |
| Sep 19, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Amlan Ray for Alkem Laboratories Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Sep 19, 2019 | 95 | Main Document (18) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Hetero USA Inc., Annora Pharma Private Limited. (Attachments: # (1) Certificate of Service)(Harmon, Kate) |
| Sep 19, 2019 | 95 | Certificate of Service (1) |
| Sep 19, 2019 | 96 | Main Document (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Drugs Limited, Corporate Parent Hetero Labs Limited for Hetero USA Inc., Hetero USA Inc. filed by Hetero USA Inc.. (Attachments: # (1) Certificate of Service)(Harmon, Kate) |
| Sep 19, 2019 | 96 | Certificate of Service (1) |
| Sep 19, 2019 | 97 | Main Document (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Labs Limited for Annora Pharma Private Limited, Annora Pharma Private Limited filed by Annora Pharma Private Limited. (Attachments: # (1) Certificate of Service)(Harmon, Kate) |
| Sep 19, 2019 | 97 | Certificate of Service (1) |
| Sep 19, 2019 | 98 | Answer to Complaint (22) Docket Text: ANSWER to [1] Complaint, Defenses, and, COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Laurus Generics Inc., Laurus Labs Ltd..(Cole, Jeremy) |
| Sep 19, 2019 | 99 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying filed by Laurus Generics Inc., Laurus Labs Ltd.. (Cole, Jeremy) |
| Sep 18, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [94] MOTION for Pro Hac Vice Appearance of Attorney Amlan Ray filed by Alkem Laboratories Ltd. Signed by Judge Colm F. Connolly on 9/18/2019. (fms) |
| Sep 17, 2019 | 94 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amlan Ray - filed by Alkem Laboratories Ltd.. (Belgam, Neal) |
| Sep 16, 2019 | 93 | Notice of Service (19) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Preliminary Infringement Contentions Against Mankind for its ANDA Product Associated with ANDA No. 212283 for U.S. Patent No. 10,258,637; (2) Plaintiffs' Preliminary Infringement Contentions Against Lupin for its ANDA Product Associated with ANDA No. 212331 for U.S. Patent No. 10,258,637; (3) Plaintiffs' Preliminary Infringement Contentions Against Lupin for its ANDA Products Associated with ANDA No. 212335 for U.S. Patent No. 10,258,637; (4) Plaintiffs' Preliminary Infringement Contentions Against Alkem for its ANDA Product Associated with ANDA No. 212382 for U.S. Patent No. 10,258,637; (5) Plaintiffs' Preliminary Infringement Contentions Against Alkem for its ANDA Products Associated with ANDA No. 212366 for U.S. Patent No. 10,258,637; (6) Plaintiffs' Preliminary Infringement Contentions Against Laurus for its ANDA Product Associated with ANDA No. 212421 for U.S. Patent No. 10,258,637; (7) Plaintiffs' Preliminary Infringement Contentions Against Zydus for its ANDA Product Associated with ANDA No. 212138 for U.S. Patent No. 10,258,637; (8) Plaintiffs' Preliminary Infringement Contentions Against Zydus for its ANDA Products Associated with ANDA No. 212198 for U.S. Patent No. 10,258,637; (9) Plaintiffs' Preliminary Infringement Contentions Against Sun for its ANDA Product Associated with ANDA No. 212343 for U.S. Patent No. 10,258,637; (10) Plaintiffs' Preliminary Infringement Contentions Against Sun for its ANDA Products Associated with ANDA No. 212339 for U.S. Patent No. 10,258,637; (11) Plaintiffs' Preliminary Infringement Contentions Against DRL for its ANDA Product Associated with ANDA No. 212336 for U.S. Patent No. 10,258,637; (12) Plaintiffs' Preliminary Infringement Contentions Against Aizant for its ANDA Product Associated with ANDA No. 212322 for U.S. Patent No. 10,258,637; (13) Plaintiffs' Preliminary Infringement Contentions Against Annora for its ANDA Product Associated with ANDA No. 212365 for U.S. Patent No. 10,258,637; (14) Plaintiffs' Preliminary Infringement Contentions Against Prinston for its ANDA Product Associated with ANDA No. 212264 for U.S. Patent No. 10,258,637; (15) Plaintiffs' Preliminary Infringement Contentions Against Invagen for its ANDA Product Associated with ANDA No. 212330 for U.S. Patent No. 10,258,637; and (16) Plaintiffs' Preliminary Infringement Contentions Against Cipla for its ANDA Product Associated with ANDA No. 212243 for U.S. Patent No. 10,258,637 -- filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Sep 13, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [90] MOTION for Pro Hac Vice Appearance of Attorney Hyun Min Han filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Lupin Pharmaceuticals, Inc., Ohm Laboratories, Inc., MSN Pharmaceuticals Inc., Cipla Limited, Cipla USA, Inc., InvaGen Pharmaceuticals, Inc., MSN Laboratories Private Ltd., Lupin Ltd. Signed by Judge Colm F. Connolly on 9/13/2019. (fms) |
| Sep 13, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Hyun Min Han for Cipla Limited, for Cipla USA, Inc., for Dr. Reddy's Laboratories, Inc., for Dr. Reddy's Laboratories, Ltd., for InvaGen Pharmaceuticals, Inc., for Lupin Ltd., for Lupin Pharmaceuticals, Inc., for MSN Laboratories Private Ltd., for MSN Pharmaceuticals Inc., for Ohm Laboratories, Inc., for Sun Pharmaceutical Industries Limited, for Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Sep 13, 2019 | 91 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s and Cadila Healthcare Limited's Initial Invalidity Contentions Pursuant to Paragraph 4(d) Concerning U.S. Patent No. 7,579,449 filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Sep 13, 2019 | 92 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Aizant Drug Research Solutions Pvt. Ltd., Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., Alkem Laboratories Ltd., Annora Pharma Private Limited, Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Cadila Healthcare Limited, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hetero USA Inc., InvaGen Pharmaceuticals, Inc., Laurus Generics Inc., Laurus Labs Ltd., Lifestar Pharma LLC, Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Mankind Pharma Ltd., Ohm Laboratories, Inc., Prinston Pharmaceutical Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Sep 12, 2019 | 90 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Hyun Min Han - filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Bilson, David) |
| Sep 11, 2019 | 85 | SO ORDERED (12) Docket Text: SO ORDERED, re (83 in 1:18-cv-01689-CFC-SRF, 9 in 1:19-cv-01499-CFC, 8 in 1:19-cv-01498-CFC, 8 in 1:19-cv-01494-CFC, 7 in 1:19-cv-01492-CFC, 8 in 1:19-cv-01495-CFC, 8 in 1:19-cv-01501-CFC, 8 in 1:19-cv-01596-CFC, 9 in 1:19-cv-01500-CFC, 9 in 1:19-cv-01493-CFC, 8 in 1:19-cv-01594-CFC, 8 in 1:19-cv-01497-CFC, 7 in 1:19-cv-01496-CFC) STIPULATION Stipulation and [Proposed] Order for Consolidation. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-1689-CFC. Plaintiffs and Defendants shall follow the Scheduling Order entered in the Consolidated Action except for those deadlines outlined in this order. Signed by Judge Colm F. Connolly on 9/9/2019. Associated Cases: 1:18-cv-01689-CFC-SRF et al.(nmf) |
| Sep 11, 2019 | 86 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Mankind Pharma Ltd.'s and Lifestar Pharma LLC's Initial Disclosures ('637 Patent) filed by Lifestar Pharma LLC, Mankind Pharma Ltd..(Orlacchio, Adam) |
| Sep 11, 2019 | 87 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Zydus Pharmaceuticals (USA) Inc.'s and Cadila Healthcare Limited's Rule 26(A)(1) Initial Disclosures; and (2) Zydus Pharmaceuticals (USA) Inc.'s and Cadila Healthcare Limited's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Sep 11, 2019 | 88 | Notice of Service (19) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Rule 26(a) Disclosures and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Sep 11, 2019 | 89 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alkem Laboratories Ltd.'s Disclosures Pursuant to Rule 26(a)(1) and Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ('637 Patent) filed by Alkem Laboratories Ltd..(Belgam, Neal) |
| Sep 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andrew C. Ryan for Alembic Pharmaceuticals Ltd., for Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Sep 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Nicholas A. Geiger for Alembic Pharmaceuticals Ltd., for Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Sep 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Steven M. Coyle for Alembic Pharmaceuticals Ltd., for Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Aug 30, 2019 | 83 | Stipulation (12) Docket Text: STIPULATION Stipulation and [Proposed] Order for Consolidation by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Aug 30, 2019 | 84 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions Against Zydus for its ANDA Products Associated with ANDA No. 213345 for U.S. Patent Nos. 7,579,449; 7,713,938; 8,551,957; 9,949,998 and 10,258,637 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Aug 21, 2019 | 82 | SO ORDERED (6) Docket Text: SO ORDERED, re (79 in 1:18-cv-01689-CFC-SRF, 12 in 1:19-cv-01295-CFC) Stipulation filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. C.A. No. 19-1295 (CFC) shall be consolidated with C.A. No. 18-1689 (CFC)( consolidated) for all purposes, and all papers shall be filed in C.A. No. 18-1689 (CFC)( consolidated); Signed by Judge Colm F. Connolly on 8/21/2019. Associated Cases: 1:18-cv-01689-CFC-SRF, 1:19-cv-01295-CFC(fms) |
| Aug 16, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Certification by Counsel has been added to D.I. [81]. (fms) |
| Aug 16, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [81] MOTION for Pro Hac Vice Appearance of Attorney Brett Garrison filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 8/16/2019. (fms) |
| Aug 16, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Brett M. Garrison for Cadila Healthcare Limited and Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 16, 2019 | 81 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Brett Garrison - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) (Additional attachment(s) added on 8/16/2019: # (1) Certification) (fms). |
| Aug 16, 2019 | 81 | Certification (1) |
| Aug 15, 2019 | 80 | Notice of Change of Address (1) Docket Text: NOTICE of Change of Address by Kelly E. Farnan (Farnan, Kelly) |
| Aug 9, 2019 | 79 | Stipulation (6) Docket Text: STIPULATION and Proposed Order Regarding Consolidation of Cases by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jul 3, 2019 | 72 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Preliminary Infringement Contentions Against Lupin for its ANDA Product Associated with ANDA No. 212331 for U.S. Patent Nos. 8,551,957 and 9,949,998; and (2) Plaintiffs' Preliminary Infringement Contentions Against Lupin for its ANDA Products Associated with ANDA No. 212335 for U.S. Patent Nos. 8,551,957 and 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 3, 2019 | 73 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Preliminary Infringement Contentions Against Macleods for its ANDA Product Associated with ANDA No. 212372 for U.S. Patent Nos. 7,713,938; 8,551,957 and 9,949,998; (2) Plaintiffs' Preliminary Infringement Contentions Against Macleods for its ANDA Products Associated with ANDA No. 212373 for U.S. Patent No. 7,713,938; and (3) Plaintiffs' Preliminary Infringement Contentions Against Macleods for its ANDA Products Associated with ANDA No. 212375 for U.S. Patent Nos. 8,551,957 and 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 3, 2019 | 74 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions Against Mankind for its ANDA Product Associated with ANDA No. 212283 for U.S. Patent Nos. 8,551,957 and 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 3, 2019 | 75 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Preliminary Infringement Contentions Against MSN for its ANDA Product Associated with ANDA No. 212358 for U.S. Patent No. 9,949,998; (2) Plaintiffs' Preliminary Infringement Contentions Against MSN for its ANDA Products Associated with ANDA No. 212359 for U.S. Patent Nos. 8,551,957 and 9,949,998; and (3) Plaintiffs' Preliminary Infringement Contentions Against MSN for its ANDA Products Associated with ANDA No. 212362 for U.S. Patent No. 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 3, 2019 | 76 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions Against Prinston for its ANDA Products Associated with ANDA No. 212264 for U.S. Patent Nos. 8,551,957 and 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 3, 2019 | 77 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Preliminary Infringement Contentions Against Zydus for its ANDA Products Associated with ANDA No. 212198 for U.S. Patents No. 7,579,449 & 7,713,938; and (2) Plaintiffs' Preliminary Infringement Contentions Against Zydus for its ANDA Product Associated with ANDA No. 212138 for U.S. Patent Nos. 7,579,449; 7,713,938 and 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 3, 2019 | 78 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Preliminary Infringement Contentions Against Sun for its ANDA Product Associated with ANDA No. 212343 for U.S. Patent Nos. 8,551,957 and 9,949,998; and (2) Plaintiffs' Preliminary Infringement Contentions Against Sun for its ANDA Products Associated with ANDA No. 212339 for U.S. Patent Nos. 8,551,957 and 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 2, 2019 | 63 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions Against Aizant for its ANDA Product Associated with ANDA No. 212322 for U.S. Patent Nos. 8,551,957 and 9,949,998 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 2, 2019 | 64 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Preliminary Infringement Contentions Against Alembic for its ANDA Products Associated with ANDA No. 212354 for U.S. Patent No. 9,949,998; (2) Plaintiffs' Preliminary Infringement Contentions Against Alembic for its ANDA Product Associated with ANDA No. 212355 for U.S. Patent No. 9,949,998; and (3) Plaintiffs' Preliminary Infringement Contentions Against Alembic for its ANDA Products Associated with ANDA No. 212394 for U.S. Patent No. 7,713,938, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 2, 2019 | 65 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Preliminary Infringement Contentions Against Alkem for its ANDA Products Associated with ANDA No. 212366 for U.S. Patent Nos. 7,713,938; 8,551,957 and 9,949,998; and (2) Plaintiffs' Preliminary Infringement Contentions Against Alkem for its ANDA Product Associated with ANDA No. 212382 for U.S. Patent Nos. 7,713,938; 8,551,957 and 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 2, 2019 | 66 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Preliminary Infringement Contentions Against Annora for its ANDA Products Associated with ANDA No. 212364 for U.S. Patent Nos. 8,551,957 and 9,949,998; and (2) Plaintiffs' Preliminary Infringement Contentions Against Annora for its ANDA Product Associated with ANDA No. 212365 for U.S. Patent Nos. 8,551,957 and 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 2, 2019 | 67 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Preliminary Infringement Contentions Against Aurobindo for its ANDA Products Associated with ANDA No. 212370 for U.S. Patent Nos. 7,713,938; 8,551,957 and 9,949,998; (2) Plaintiffs' Preliminary Infringement Contentions Against Aurobindo for its ANDA Product Associated with ANDA No. 212371 for U.S. Patent Nos. 7,713,938 and 9,949,998; (3) Plaintiffs' Preliminary Infringement Contentions Against Aurobindo for its ANDA Products Associated with ANDA No. 212349 for U.S. Patents No. 7,713,938 & 9,949,998; and (4) Plaintiffs' Preliminary Infringement Contentions Against Aurobindo for its ANDA Products Associated with ANDA No. 212374 for U.S. Patent No. 7,713,938, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 2, 2019 | 68 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions Against Cipla for its ANDA Products Associated with ANDA No. 212243 for U.S. Patent No. 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 2, 2019 | 69 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions Against DRL for its ANDA Product Associated with ANDA No. 212336 for U.S. Patent Nos. 7,713,938 and 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 2, 2019 | 70 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions Against InvaGen for its ANDA Product Associated with ANDA No. 212330 for U.S. Patent No. 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jul 2, 2019 | 71 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions Against Laurus for its ANDA Product Associated with ANDA NO. 212421 for U.S. Patent Nos. 7,579,449 and 9,949,998, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| May 9, 2019 | 62 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Paragraph 3 Initial Disclosures re [20] Scheduling Order,,, [1] Complaint, filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Connolly, Arthur) |
| May 6, 2019 | 57 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alkem Laboratories Ltd.'s Core Technical Documents pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Alkem Laboratories Ltd..(Ormerod, Eve) |
| May 6, 2019 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Mankind Pharma Ltd.'s and Lifestar Pharma LLC's Core Technical Documents filed by Lifestar Pharma LLC, Mankind Pharma Ltd..(Orlacchio, Adam) |
| May 6, 2019 | 59 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Pharmaceuticals, Ltd. and Alembic Pharmaceuticals, Inc.'s Core Technical Documents pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Farnan, Kelly) |
| May 6, 2019 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of core technical documents filed by Aizant Drug Research Solutions Pvt. Ltd..(Stamoulis, Stamatios) |
| May 6, 2019 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of core technical documents filed by Prinston Pharmaceutical Inc..(Stamoulis, Stamatios) |
| May 3, 2019 | 54 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Letter to Plaintiffs' counsel verifying the October 20, 2018 production of the core technical documents filed by Laurus Generics Inc., Laurus Labs Ltd..(Cole, Jeremy) |
| May 3, 2019 | 55 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Farnan, Kelly) |
| May 3, 2019 | 56 | Notice (Other) (2) Docket Text: NOTICE of Service by Annora Pharma Private Limited (Harmon, Kate) |
| Apr 29, 2019 | 53 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove David C. Kistler as co-counsel.. (Orlacchio, Adam) |
| Apr 25, 2019 | 42 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendant Mankind Pharma Ltd.'s Supplemental Initial Disclosures and (ii) Defendant Lifestar Pharma LLC's Supplemental Initial Disclosures filed by Lifestar Pharma LLC, Mankind Pharma Ltd..(Orlacchio, Adam) |
| Apr 25, 2019 | 43 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Disclosures Pursuant to Delawares Default Standard for Discovery filed by Hetero USA Inc..(Harmon, Kate) |
| Apr 25, 2019 | 44 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Disclosures Pursuant to Delawares Default Standard for Discovery filed by Annora Pharma Private Limited.(Harmon, Kate) |
| Apr 25, 2019 | 45 | Notice of Service (16) Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Apr 25, 2019 | 46 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Sun Pharmaceutical Industries Limited and Sun Pharmaceuticals Industries, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; (2) Invagen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; (3) Cipla Limited and Cipla USA, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; (4) Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; (5) Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; and (6) MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc..(Bilson, David) |
| Apr 25, 2019 | 47 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s and Cadila Healthcare Limited's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Apr 25, 2019 | 48 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alkem Laboratories Ltd.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Alkem Laboratories Ltd..(Ormerod, Eve) |
| Apr 25, 2019 | 49 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Defendants' Paragraph 3 Disclosures Regarding Discovery filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Farnan, Kelly) |
| Apr 25, 2019 | 50 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Disclosures filed by Laurus Generics Inc., Laurus Labs Ltd..(Cole, Jeremy) |
| Apr 25, 2019 | 51 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Aizant Drug Research Solutions Pvt. Ltd..(Stamoulis, Stamatios) |
| Apr 25, 2019 | 52 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Prinston Pharmaceutical Inc..(Stamoulis, Stamatios) |
| Apr 24, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [41] STIPULATION TO EXTEND TIME for Initial ESI Disclosures to May 9, 2019 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Colm F. Connolly on 4/24/2019. (fms) |
| Apr 23, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [40] MOTION for Pro Hac Vice Appearance of Attorney Jonathan M. Knowles filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 4/23/2019. (fms) |
| Apr 23, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jonathan M. Knowles for Cadila Healthcare Limited and Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (amf) |
| Apr 23, 2019 | 40 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jonathan M. Knowles - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # (1) Certification of Jonathan M. Knowles)(Bilson, David) |
| Apr 23, 2019 | 40 | Certification of Jonathan M. Knowles (1) |
| Apr 23, 2019 | 41 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Initial ESI Disclosures to May 9, 2019 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Apr 15, 2019 | 39 | Notice (Other) (2) Docket Text: NOTICE of Change of Firm Affiliation - Anandita Vyakarnam by Alkem Laboratories Ltd. (Ormerod, Eve) |
| Apr 8, 2019 | 38 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Defendants' Initial Disclosures filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Farnan, Kelly) |
| Apr 4, 2019 | 37 | Protective Order (30) Docket Text: PROTECTIVE ORDER Signed by Judge Colm F. Connolly on 4/4/2019. (nmf) |
| Apr 3, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [34] STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to April 3, 2019 filed by Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Alembic Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 4/3/2019. (fms) |
| Apr 3, 2019 | 35 | Proposed Order (30) Docket Text: Stipulated Protective Order by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) Modified on 4/8/2019 (lih). |
| Apr 3, 2019 | 36 | Notice of Service (19) Docket Text: NOTICE OF SERVICE of Plaintiffs Identification of Asserted Patents (as to Defendants Mankind Pharma Ltd, Lifestar Pharma LLC, Lupin Ltd, Lupin Pharmaceuticals, Inc., Alkem Laboratories, Ltd, Aurobindo Pharma Ltd, Aurobindo Pharma USA, Inc., Laurus Labs, Ltd, Laurus Generics Inc., Alembic Pharmaceuticals Ltd, Alemic Pharmaceuticals, Inc., Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited, Macleods Pharmaceuticals, Ltd, Macleods Pharma USA Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories, Inc., Aizant Drug Research Solutions Pvt. Ltd., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Annora Pharma Private Ltd., Prinston Pharmaceutical Inc., InvaGen Pharmaceuticals, Inc.. Cipla Limited and Cipla USA, Inc.) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Apr 2, 2019 | 34 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to April 3, 2019 - filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Farnan, Kelly) |
| Apr 1, 2019 | 33 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Rule 26 Initial Disclosures filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Connolly, Arthur) |
| Mar 27, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [32] Joint STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to April 2, 2019 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 3/27/2019. (fms) |
| Mar 26, 2019 | 24 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Kate Harmon on behalf of Annora Pharma Private Limited, Hetero USA Inc. (Harmon, Kate) |
| Mar 26, 2019 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Hetero USA Inc.'s Initial Disclosures filed by Annora Pharma Private Limited, Hetero USA Inc..(Harmon, Kate) |
| Mar 26, 2019 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Annora Pharma Private Ltd.'s Initial Disclosures filed by Annora Pharma Private Limited, Hetero USA Inc..(Harmon, Kate) |
| Mar 26, 2019 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alkem Laboratories Ltd.'s Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Alkem Laboratories Ltd..(Ormerod, Eve) |
| Mar 26, 2019 | 28 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s and Cadila Healthcare Limited's Rule 26(a)(1) Initial Disclosures filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Mar 26, 2019 | 29 | Notice of Service (16) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a) Initial Disclosures filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Mar 26, 2019 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc.s Initial Disclosures Pursuant to Rule 26(a)(1); (2) Invagen Pharmaceuticals, Inc.s Initial Disclosures Pursuant to Rule 26(a)(1); (3) Cipla Limited and Cipla USA, Inc.s Initial Disclosures Pursuant to Rule 26(a)(1); (4) Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.s Initial Disclosures Pursuant to Rule 26(a)(1); (5) Dr. Reddys Laboratories Ltd. and Dr. Reddys Laboratories, Inc.s Initial Disclosures Pursuant to Rule 26(a)(1) and (6) MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.s Initial Disclosures Pursuant to Rule 26(a)(1) filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc..(Bilson, David) |
| Mar 26, 2019 | 31 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Rule 26(a)(1) Initial Disclosures filed by Laurus Generics Inc., Laurus Labs Ltd..(Cole, Jeremy) |
| Mar 26, 2019 | 32 | Stipulation to EXTEND Time (4) Docket Text: Joint STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to April 2, 2019 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Mar 22, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin E. Warner for Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Mar 21, 2019 | 23 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Macleods Pharmaceuticals, Ltd. and Macleods Pharma USA Inc.'s (1) Initial Disclosures Pursuant to the Delaware Default Standard, paragraph 3 and (2) Rule 26(a)(1) Initial Disclosures filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Farnan, Kelly) |
| Mar 19, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Charles B. Klein and Ryan B. Hauer for Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, and Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
| Mar 19, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Bryce A. Cooper for Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
| Mar 18, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [22] MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi, Charles B. Klein, Michael K. Nutter, Kevin E. Warner, Kurt A. Mathas, Jovial Wong, Bryce A. Cooper, Christopher B. Essig and Ryan B. Hauer filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Lupin Pharmaceuticals, Inc., MSN Pharmaceuticals Inc., Cipla Limited, Cipla USA, Inc., InvaGen Pharmaceuticals, Inc., MSN Laboratories Private Ltd., Lupin Ltd. Signed by Judge Colm F. Connolly on 3/18/2019. (fms) |
| Mar 15, 2019 | 22 | Motion for Leave to Appear Pro Hac Vice (11) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi, Charles B. Klein, Michael K. Nutter, Kevin E. Warner, Kurt A. Mathas, Jovial Wong, Bryce A. Cooper, Christopher B. Essig and Ryan B. Hauer - filed by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Bilson, David) |
| Mar 14, 2019 | 21 | Notice (Other) (2) Docket Text: NOTICE of of Withdrawal of Appearance and of Electronic Notification Only as to Pro Hac Vice Attorney Daniel J. Ritterbeck by Laurus Generics Inc., Laurus Labs Ltd. (Cole, Jeremy) |
| Mar 5, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-01689-CFC-SRF et al.(cak) |
| Mar 5, 2019 | 20 | Scheduling Order (21) Docket Text: SCHEDULING & CONSOLIDATION ORDER: These actions are consolidated for all purposes and all papers shall be filed in Lead Case No. 18-1689-CFC. Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for all disputes relating to discovery matters and protective orders. Joinder of Parties due by 4/30/2020. Amended Pleadings due by 4/30/2020. Fact Discovery completed by 3/22/2020. Joint Claim Construction Brief due by 2/28/2020. A Markman Hearing is set for 4/7/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 4/8/2021 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 4/19/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 3/4/2019. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Mar 4, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 3/4/2019. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Feb 28, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Reset Hearings: The Scheduling Conference on 3/4/2019 at 02:30 PM before Judge Colm F. Connolly is rescheduled as a Telephonic Scheduling Conference per the letter and proposed scheduling order filed today stating that there are no areas of dispute. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Feb 28, 2019 | 19 | Main Document (21) Docket Text: PROPOSED ORDER -- [Proposed] Scheduling Order -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Egan, Brian) |
| Feb 28, 2019 | 19 | Letter to The Honorable Colm F. Connolly (2) |
| Feb 1, 2019 | 18 | Answer to Counterclaim (9) Docket Text: ANSWER to [13] Answer to Complaint,, Counterclaim, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jan 16, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jay P. Lessler and David C. Kistler for Lifestar Pharma LLC and Mankind Pharma Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Jan 15, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [17] MOTION for Pro Hac Vice Appearance of Attorney Jay P. Lessler and David C. Kistler filed by Lifestar Pharma LLC, Mankind Pharma Ltd. Signed by Judge Colm F. Connolly on 1/15/2019. (fms) |
| Jan 15, 2019 | 17 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jay P. Lessler and David C. Kistler - filed by Lifestar Pharma LLC, Mankind Pharma Ltd.. (Orlacchio, Adam) |
| Jan 11, 2019 | 13 | Answer to Complaint (24) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Lifestar Pharma LLC, Mankind Pharma Ltd..(Orlacchio, Adam) |
| Jan 11, 2019 | 14 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Mankind Pharma Ltd.. (Orlacchio, Adam) |
| Jan 11, 2019 | 15 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Lifestar Pharma LLC. (Orlacchio, Adam) |
| Jan 11, 2019 | 16 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendant Mankind Pharma Ltd.'s Rule 26 Initial Disclosures and (ii) Defendant Lifestar Pharma LLC's Rule 26 Initial Disclosures filed by Lifestar Pharma LLC, Mankind Pharma Ltd..(Orlacchio, Adam) |
| Jan 3, 2019 | 12 | Order Setting Scheduling Conference (9) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 3/4/2019 at 02:30 PM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/3/2019. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Dec 28, 2018 | 11 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding coordinated discovery and Markman proceedings, and to request a scheduling conference. (Blumenfeld, Jack) |
| Dec 17, 2018 | 10 | Order (8) Docket Text: ORDER, IT IS ORDERED that, on or before January 2, 2019, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/2/2019.) Signed by Judge Colm F. Connolly on 12/17/2018. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Nov 30, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] Stipulation filed by Lifestar Pharma LLC, Mankind Pharma Ltd., Set/Reset Answer Deadlines: Lifestar Pharma LLC answer due 1/11/2019; Mankind Pharma Ltd. answer due 1/11/2019. Signed by Judge Colm F. Connolly on 11/30/2018. (fms) |
| Nov 30, 2018 | 8 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Adam V. Orlacchio on behalf of Lifestar Pharma LLC, Mankind Pharma Ltd. (Orlacchio, Adam) |
| Nov 30, 2018 | 9 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Extend Time for Defendants to Answer, Move or Otherwise Respond to the Complaint re [1] Complaint, by Lifestar Pharma LLC, Mankind Pharma Ltd.. (Orlacchio, Adam) |
| Nov 20, 2018 | 7 | Declaration (9) Docket Text: DECLARATION of Mailing on Mankind Pharma Ltd. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) |
| Nov 19, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation. Lifestar Pharma LLC served on 11/19/2018, answer due 12/10/2018. (Blumenfeld, Jack) |
| Oct 31, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-01689-CFC, 1:18-cv-01690-CFC (rjb) |
| Oct 29, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lifestar Pharma LLC on 10/29/2018; Mankind Pharma Ltd. on 10/29/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| Oct 26, 2018 | 1 | Main Document (12) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Lifestar Pharma LLC, Mankind Pharma Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2490941.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation. (Attachments: # (1) Exhibits 1-2, # (2) Civil Cover Sheet)(ceg) |
| Oct 26, 2018 | 1 | Exhibits 1-2 (87) |
| Oct 26, 2018 | 1 | Civil Cover Sheet (1) |
| Oct 26, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Oct 26, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/19/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 2/1/2022. (ceg) |
| Oct 26, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,551,957; 9,949,998. (ceg) |
| Oct 26, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (ceg) |
| Oct 26, 2018 | 1 | Complaint* (1) |
